Presentation Type: e-Poster

Press Ctrl+F to search your abstract.


Topic/Category Presentation Code Abstract Title Presenting Author Presenting Author Affiliation Country/Region Original Submission ID
01: IBD: Clinical - Epidemiology EP-001 Sex-Specific Differences in Malignancy Risk Among Korean Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study Jeongkuk Seo Chung-Ang University College of Medicine Korea OK0470
01: IBD: Clinical - Epidemiology EP-002 Impact of Metabolic Dysfunction-Associated Steatotic Liver Disease on Adverse Clinical Outcomes in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis Jong Yoon Lee Dong-A University College of Medicine Korea PK0033
01: IBD: Clinical - Epidemiology EP-003 Impact of Environmental Risk Factors in Early Life on the Development of Inflammatory Bowel Disease Ha Won Im Seoul National University Hospital Korea OK0401
01: IBD: Clinical - Epidemiology EP-004 The Epidemiology of Inflammatory Bowel Disease: Assessing the Impact of Economic Development on Disease Burden from 1990 to 2021 Yutong Cheng The Second Affiliated Hospital of Xi'an Jiaotong University China OF0256
01: IBD: Clinical - Epidemiology EP-005 Comparison of Clinical Characteristics and Outcomes Between Ileal and Colonic Crohn's Disease in Korea: Results from the Prospective CONNECT Study Jiyoung Yoon Kangdong Sacred Heart Hospital, Hallym University College of Medicine Korea PK0339
01: IBD: Clinical - Epidemiology EP-006 Dietary Patterns and Nutritional Inadequacy in Patients with Inflammatory Bowel Disease in Remission: A Comparative Analysis of Crohn's Disease and Ulcerative Colitis Tianjiao Zhang Division of Gastroenterology and Hepatology, National University Hospital Singapore OF0347
01: IBD: Clinical - Epidemiology EP-007 Prevalence and Risk Factors of Low Bone Mineral Density and Low Muscle Mass in Patients with Inflammatory Bowel Disease I-Lun Shih National Taiwan University Hospital Taiwan PF0333
01: IBD: Clinical - Epidemiology EP-008 Avoidant/Restrictive Food Intake Disorder Risk Is Associated with Depressive Symptoms in Inflammatory Bowel Disease Natchaporn Noppacroh The Chinese University of Hong Kong, Phramongkutklao hospital Thailand OF0282
01: IBD: Clinical - Epidemiology EP-009 Risk of Myocardial Infarction in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study Gisok Kang Yonsei University Wonju College of Medicine Korea OK0313
01: IBD: Clinical - Epidemiology EP-011 The Perception of Diet Pattern and Therapy Among Patients with Inflammatory Bowel Disease in China: A Cross-Sectional Survey Ni Ding The Sixth Affiliated Hospital, Sun Yat-sen University China OF0201
01: IBD: Clinical - Epidemiology EP-012 Higher Prevalence and Psychosocial Burden of IBS in IBD Patients: A Rome IV-Based Comparative Analysis Dong Woo Kim Busan Paik Hospital, Inje University College of Medicine Korea PK0235
01: IBD: Clinical - Epidemiology EP-013 Epidemiological Study of Colitis-Associated Colorectal Cancer in Patient with Inflammatory Bowel Disease: A Single Institute Experience in Taiwan Jen-Wei Chou China Medical University Hospital, China Medical University, Taiwan Association for the Study of Intestinal Diseases (TASID) Taiwan PF0040
01: IBD: Clinical - Epidemiology EP-014 Determinants of Anxiety Toward Self-Injection Therapy in Patients with Inflammatory Bowel Disease Kento Imamura Tohoku University Hospital Japan PF0117
01: IBD: Clinical - Epidemiology EP-015 Risk of Cerebral Infarction in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study Hee Chan Moon Yonsei University Wonju College of Medicine Korea OK0312
01: IBD: Clinical - Epidemiology EP-016 Psychological Morbidity in Asian IBD: Prevalence, Clinical Impact and Integration of Routine Psychosocial Screening Jonathan Tian En Koh Tan Tock Seng Hospital Singapore OF0344
01: IBD: Clinical - Epidemiology EP-017 Antibiotic Marketplace Density and Ultra-Processed Food Exposure Are Linked to Younger-Age Inflammatory Bowel Disease Presentation Across Rapidly Urbanizing Corridors in Asia and Other Newly Industrialized Areas Irish Merlyn Alvarez National University of Dasmarinas Philippines OF0432
01: IBD: Clinical - Epidemiology EP-018 Mendelian Randomization and Polygenic Risk Triangulation Identify Therapy-Relevant Immune Trafficking and Epithelial Barrier Axes in Inflammatory Bowel Disease Prihantini Prihantini IMCDS-BioMed Research Foundation Indonesia PF0433
01: IBD: Clinical - Epidemiology EP-019 Characterization of the Global Spatiotemporal Co-Burden and Geographic Inequality of Inflammatory Bowel Disease and Depressive Disorders, from 1990-2021: An Analysis of GBD 2021 Database Jingzheng Jin General Hospital of Tianjin Medical University China PF0178
01: IBD: Clinical - Epidemiology EP-020 The Global Burden of Nutritional Disorders in Inflammatory Bowel Disease Shiyu Xiao Sichuan Provincial People's Hospital, Sichuan Provincial People's Hospital China OF0063
01: IBD: Clinical - Epidemiology EP-021 Integrating Global Epidemiological Trends and Molecular Insights: a-Linolenic Acid Metabolism as a Potential Link Between IBD and Depression Zi-Ru Zhou The Affiliated Wuxi People's Hospital of Nanjing Medical University China OF0025
01: IBD: Clinical - Epidemiology EP-022 Cross-Cultural Adaptation and Clinical Psychometric Evaluation of the Chinese Version of the IBD-Control Questionnaire in Chinese Patients with Inflammatory Bowel Disease Zhenzhen Zhai Qilu Hospital of Shandong University Dezhou Hospital China PF0253
01: IBD: Clinical - Epidemiology EP-023 Circulating Metabolite Signatures Linking Physical Activity to Inflammatory Bowel Disease Risk and Interactions with Genetic Susceptibility Zi Xuan He Changhai Hospital,Naval Medical University China OF0299
01: IBD: Clinical - Epidemiology EP-024 Association Between ABO Blood Type and Clinical Characteristics in Inflammatory Bowel Disease in Taiwan Chien-Yun Hou China Medical University Hospital Taiwan OF0163
01: IBD: Clinical - Epidemiology EP-025 Is Clostridioides difficile Superinfection a Major Causative Factor for Acute Flares Associated with Moderate to Severe Ulcerative Colitis in Northern India? Amarender Puri Medanta The Medicity India OF0325
01: IBD: Clinical - Epidemiology EP-026 Accelerometer-Measured Moderate-to-Vigorous Physical Activity Is Associated with Reduced Risk of Bowel Resection and Mortality in Inflammatory Bowel Disease: A Prospective Cohort Study Zi Xuan He Changhai Hospital ,Naval Medical University China OF0289
01: IBD: Clinical - Epidemiology EP-028 Post-Marketing Safety Profiles of Risankizumab and Guselkumab: A Comparative Analysis of FAERS and JADER Pharmacovigilance Signals Wei Tan Chongqing General Hospital China PF0131
01: IBD: Clinical - Epidemiology EP-029 Low Serum Uric Acid Levels Are Associated with Low Bone Mineral Density in Male Patients with Ulcerative Colitis Dongwoo Kim Korea University College of Medicine Korea PK0311
01: IBD: Clinical - Epidemiology EP-030 Determinants of Vitamin D Deficiency and Supplementation Patterns in Patients with Inflammatory Bowel Disease Dongkyung Shin St. Vincent's Hospital, College of Medicine, The Catholic University of Korea Korea PK0390
01: IBD: Clinical - Epidemiology EP-031 Inflammatory Bowel Disease (IBD) in an Emerging Gastroenterology Service Centre in Malaysia: Younger Age with Increased Severity Nabilah Izham Gastroenterology and Hepatology Service Centre, Hospital Al-Sultan Abdullah, Universiti Teknologi MARA, Selangor, Malaysia Malaysia PF0335
01: IBD: Clinical - Epidemiology EP-033 Discontinuation of Inflammatory Bowel Diseases Clinical Studies: A Cross-Sectional Analysis Yousef Radwan Alnomani Faculty of Medicine, Benha University Egypt OF0449
01: IBD: Clinical - Epidemiology EP-035 Age and Sex Distribution of Inflammatory Bowel Disease Patients in Seoul Hospital of Mongolia Munkhzul Bolooj Mongolia Mongolia PF0125
02: IBD: Clinical - Diagnosis and Monitoring EP-036 Atypical Distribution Independently Influences Fecal Calprotectin Levels in Ulcerative Colitis: Beyond Endoscopic Severity and Disease Extent Jae Eun So Yonsei University College of Medicine, Severance Hospital Korea PK0237
02: IBD: Clinical - Diagnosis and Monitoring EP-037 The Risk Factor of Gastrointestinal Involvement in Patient with Behçet's Disease Jin Hwa Park University of Hanyang College of Medicine Korea PK0051
02: IBD: Clinical - Diagnosis and Monitoring EP-038 Lack of Association Between Vitamin D Status and Bone Mineral Density in Patients with Inflammatory Bowel Disease Seong Jun Kim St. Vincent's Hospital, College of Medicine, The Catholic University of Korea Korea PK0391
02: IBD: Clinical - Diagnosis and Monitoring EP-039 Predictive Value of Anti-Integrin alpha V beta 6 Antibody Titers for Therapeutic Escalation in Patients with Endoscopically Active Ulcerative Colitis Rika Shimizu Kyoto University Hospital Japan PF0381
02: IBD: Clinical - Diagnosis and Monitoring EP-040 Diagnostic Accuracy of Blood Biomarkers for Predicting Small Bowel Mucosal Remission and Correlation with Endoscopic Activity in Crohn's Disease Yoshihiro Akita The Jikei University School of Medicine Japan OF0321
02: IBD: Clinical - Diagnosis and Monitoring EP-041 Serum Amyloid a as a High-Resolution Indicator of Mucosal Healing in Ulcerative Colitis. Kotaro Akita Sapporo Medical University School of Medicine Japan PF0233
02: IBD: Clinical - Diagnosis and Monitoring EP-042 Clinical Progression and Predictors of Significant Disease in Terminal Ileitis: A 20-Year Retrospective Cohort Study Panupong Luangsirithanya Division of Gastroenterology, Faculty of Medicine Siriraj Hospital, Mahidol University Thailand OF0348
02: IBD: Clinical - Diagnosis and Monitoring EP-043 Diagnostic Accuracy of Fecal Biomarkers for Mucosal and Histological Healing in Ulcerative Colitis: A Network Meta-Analysis Yan Zhang Qilu Hospital of Shandong University China OF0232
02: IBD: Clinical - Diagnosis and Monitoring EP-044 Discordant Patterns of Lumbar Spine and Hip Bone Mineral Density in Patients with Inflammatory Bowel Disease Ji Min Lee St. Vincent's Hospital, College of Medicine, The Catholic University of Korea Korea PK0392
02: IBD: Clinical - Diagnosis and Monitoring EP-045 Optimizing Fecal Calprotectin Thresholds for Endoscopic Activity in Ulcerative Colitis Ji Eun Kim Samsung Medical Center Korea PK0324
02: IBD: Clinical - Diagnosis and Monitoring EP-046 Therapeutic Drug Monitoring of Upadacitinib in Inflammatory Bowel Disease: A Prospective Real-World Study Meng-Tzu Weng National Taiwan University Hospital and College of Medicine Taiwan OF0414
02: IBD: Clinical - Diagnosis and Monitoring EP-047 A Multicenter Observational Study on Extraintestinal Malignancies Complicating Inflammatory Bowel Disease Ryunosuke Hayashi Asahikawa Medical University Japan OF0064
02: IBD: Clinical - Diagnosis and Monitoring EP-048 Computed Tomography Enterography-Based Lemann Density Index as an Independent Predictor of Surgical Resection in Crohn's Disease: A Firth's Penalized Regression Analysis Linwei Wang Zhongshan Hospital of Xiamen University China OF0038
02: IBD: Clinical - Diagnosis and Monitoring EP-049 Fecal Lipocalin-2 Complements Calprotectin in Detecting Residual and Low-Grade Inflammation in Inflammatory Bowel Disease Qing Li The Sixth Affiliated Hospital, Sun Yat-sen University China OF0197
02: IBD: Clinical - Diagnosis and Monitoring EP-050 Unveiling the Superior Predictive Power of UCEIS and TIGER in Ulcerative Colitis Severity Xinyu Liu The Sixth Affiliated Hospital, Sun Yat-sen University, The Sixth Affiliated Hospital, Sun Yat-sen University, The Sixth Affiliated Hospital, Sun Yat-sen University China PF0271
02: IBD: Clinical - Diagnosis and Monitoring EP-051 Efficacy of Balloon Assisted Enteroscopy Using an Ultrathin Endoscope for Intestinal Stricture Yusuke Onoyama Kyoto University Japan PF0231
02: IBD: Clinical - Diagnosis and Monitoring EP-052 Risk Factors of Renal Involvement in Patients with Inflammatory Bowel Disease Xiaoping Han The First Hospital of Jilin University China OF0295
02: IBD: Clinical - Diagnosis and Monitoring EP-053 Intestinal Behçet's Disease as a Distinct Phenotype of Behçet's Disease Su Bum Park Pusan National University Yangsan Hospital Korea PK0295
02: IBD: Clinical - Diagnosis and Monitoring EP-054 Longitudinal Cholesterol Patterns and the Risk of Relapse in Ulcerative Colitis Ji-Yeon Kim Samsung Medical Center, Sungkyunkwan University School of Medicine Korea PK0446
02: IBD: Clinical - Diagnosis and Monitoring EP-055 Predictors of Steroid Resistance in Ulcerative Colitis: Added Value of the CRP/Albumin Ratio in a Vietnamese Cohort Tien Hk CK Clinic Vietnam PF0133
02: IBD: Clinical - Diagnosis and Monitoring EP-056 Comparative Analysis of Five Nutritional Tools and Construction of a Combined Nutrition-Inflammation Model for Assessing Disease Activity in Inflammatory Bowel Disease Tong Li First affiliated hospital of Dalian medical university China PF0388
02: IBD: Clinical - Diagnosis and Monitoring EP-057 Discrepancy Between MR Enterography and Endoscopy in Assessing Inflammation During Follow-up of Pediatric Crohn's Disease Hyeji Lim 1Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Severance Hospital, Yonsei University college of Medicine, Seoul, Korea Korea PK0312
02: IBD: Clinical - Diagnosis and Monitoring EP-058 Retrospective Analysis of Non-Caseating Granuloma Detection Rate in 1682 Biopsy Sites from 380 Patients with Crohn's Disease Wenwen Lu People's Hospital of Suzhou New District China PF0074
02: IBD: Clinical - Diagnosis and Monitoring EP-059 Predictive Factors for 24-Week Therapeutic Response to Ustekinumab in Crohn's Disease Ye Zhao First Affiliated Hospital of Zhengzhou University China PF0331
02: IBD: Clinical - Diagnosis and Monitoring EP-060 Baseline C-Reactive Protein as an Independent Predictor of Early Treatment Persistence with Upadacitinib in Ulcerative Colitis: A Real-World Study Kanako Ogasawara Department of Gastroenterology Japan PF0247
02: IBD: Clinical - Diagnosis and Monitoring EP-061 ANA Seroconversion and Clinical Outcomes in Ulcerative Colitis Patients Initiating Advanced Therapies: A Prospective Multicenter Study Seung Yong Shin Chung-Ang University College of Medicine Korea PK0239
02: IBD: Clinical - Diagnosis and Monitoring EP-063 A Predictive Model for Assessing Disease Activity in Inflammatory Bowel Disease: Integrating Serological Markers and Fecal Calprotectin Tong Li First affiliated hospital of Dalian medical university China OF0374
02: IBD: Clinical - Diagnosis and Monitoring EP-064 Prevalence, Types, and Quality of Life Impact of Anemia in Newly Diagnosed, Treatment-Naive Crohn's Disease Patients: A Cross-Sectional Study Kiran Josy Kanjamala Lisie Hospital India OF0350
02: IBD: Clinical - Diagnosis and Monitoring EP-065 Results of Using Fecal Calprotectin in the Diagnosis of Inflammatory Bowel Disease Maral Boldbaatar Mongolian National University of Medical Science Mongolia OF0440
02: IBD: Clinical - Diagnosis and Monitoring EP-066 Diagnostic Challenges of Crohn's Disease in a Tuberculosis-Endemic, Emerging Region: High Prevalence of Non-Specific and Malignancy-Mimicking Features Luan Minh Dang University of Medicine and Pharmacy at Ho Chi Minh City, University Medical Center Vietnam OF0079
02: IBD: Clinical - Diagnosis and Monitoring EP-067 Burden and Risk Factors of Active Inflammatory Bowel Disease Among Patients in a Tertiary Care Setting Monirujjaman Biswas National Institute of Respiratory Diseases India OF0144
02: IBD: Clinical - Diagnosis and Monitoring EP-068 Significance of Measuring Serum BDNF Concentration in Predicting Psychological Improvement in Patients with Refractory Ulcerative Colitis Kei Moriya Nara Prefecture General Medical Center Japan PF0037
02: IBD: Clinical - Diagnosis and Monitoring EP-069 The Relationship Between the Level of Calprotectin in Blood Serum and 1-Antitrypsin in Blood Serum in Patients with Inflammatory Bowel Diseases Oleg Knyazev Moscow Clinical Scientific Center named after A.S. Loginov Russian Federation PF0021
02: IBD: Clinical - Diagnosis and Monitoring EP-070 Clinical Utility of Infliximab Therapeutic Drug Monitoring in Inflammatory Bowel Disease Chih-Wen Huang Changhua Christian Hospital Taiwan PF0104
02: IBD: Clinical - Diagnosis and Monitoring EP-071 Whole Blood Transcriptomics-Based Screening of Diagnostic Markers for Ulcerative Colitis Hongru Wu Xinjiang Uygur Autonomous Region People's Hospital China PF0323
02: IBD: Clinical - Diagnosis and Monitoring EP-072 Limited Fecal Calprotectin Monitoring Obscures Active Ulcerative Colitis and Prolongs Steroid Recycling in Low-Access Communities Despite Persistent Microscopic Inflammation and Missed Opportunities for Timely Objective Reassessment Nadeem Alam Doha Institute for Graduate Studies Qatar OF0429
02: IBD: Clinical - Diagnosis and Monitoring EP-073 HBV Reactivation Risk with JAK Inhibitors in IBD: Practice Implications in HBV-Endemic Asia Huiyu Lin Tan Tock Seng Hospital Singapore PF0127
02: IBD: Clinical - Diagnosis and Monitoring EP-074 Ulcerative Colitis Mimic: Constipation-Associated Rectal Lymphoid Hyperplasia Yoshiharu Yamaguchi Aichi Medical University School of Medicine Japan PF0059
02: IBD: Clinical - Diagnosis and Monitoring EP-075 Clinical Utility of Serum Trefoil Factor 3 in Assessing Disease Activity and Mucosal Healing in Inflammatory Bowel Disease Widia Sari Faculty of Medicine, Universitas Baiturrahmah Indonesia PF0340
03: IBD: Clinical - Treatment and Prognosis EP-076 Pre-Admission Oral Prednisolone Exposure and Rescue Therapy in Acute Severe Ulcerative Colitis Jee Hyun Kim Chonnam National University Hospital, Chonnam National University Medical School Korea OK0370
03: IBD: Clinical - Treatment and Prognosis EP-077 Treatment Persistence After Switching Between Anti-TNF-alpha Agents and JAK Inhibitors in Ulcerative Colitis: A Nationwide Real-World Analysis from HIRA Ji Eun Baek St. Vincent's Hospital, College of Medicine, The Catholic University of Korea Korea PK0039
03: IBD: Clinical - Treatment and Prognosis EP-078 Impact of IBD Medication Exposure Before and After Cancer Diagnosis on Cancer Recurrence and Survival in Patients with Inflammatory Bowel Disease Jae Eun So Yonsei University College of Medicine, Severance Hospital Korea PK0414
03: IBD: Clinical - Treatment and Prognosis EP-079 Systematic Review and Network Meta-Analysis: Safety of Advanced Therapies in Pregnant Women with Inflammatory Bowel Disease Caterina Prada Gold Coast University Hospital Australia OF0048
03: IBD: Clinical - Treatment and Prognosis EP-080 Efficacy and Safety of Vedolizumab in Early Crohn's Disease: Final Results from the Prospective, Multicentre, Interventional EARLY CD Study Jing Liu Sir Run Run Shaw Hospital - Zhejiang University School of Medicine, Sir Run Run Shaw Hospital - Zhejiang University School of Medicine China OF0068
03: IBD: Clinical - Treatment and Prognosis EP-081 Efficacy and Safety of Subcutaneous Guselkumab Rescue Therapy in Moderately to Severely Active Crohn's Disease and Inadequate Response to Ustekinumab: Results from GALAXI 1, 2, & 3 Long-Term Extension Rupert W Leong Macquarie University Hospital Australia PF0049
03: IBD: Clinical - Treatment and Prognosis EP-082 Efficacy and Safety of Guselkumab Through Week 96 in Chinese Participants with Crohn's Disease: Phase 3 Long-Term Extension Data from GALAXI 2, GALAXI 3 Baili Chen The First Affiliated Hospital of Sun Yat-sen University China OF0294
03: IBD: Clinical - Treatment and Prognosis EP-083 De-Escalation Outcomes and Strategies After Advanced Combination Therapy in Difficult-to-Treat Inflammatory Bowel Disease: A Real-World Cohort Study from Taiwan Ming-Jung Meng Linkou Chang Gung Memorial Hospital Taiwan PF0258
03: IBD: Clinical - Treatment and Prognosis EP-084 Real-World Effectiveness and Safety of Guselkumab During Induction of Remission in Patients with Ulcerative Colitis Masayuki Fukata JCHO Tokyo Yamate Medical Center Japan OF0165
03: IBD: Clinical - Treatment and Prognosis EP-085 Upadacitinib as Rescue and Sequential Rescue Therapy for Acute Severe Ulcerative Colitis: An Observational Cohort Study Matthew Mansoor Gold Coast University Hospital Australia OF0246
03: IBD: Clinical - Treatment and Prognosis EP-086 Clinical Outcomes of Cytomegalovirus Reactivation in Moderate-to-Severe Ulcerative Colitis in the Era of Biologics and Small Molecules Jihye Park Yonsei University College of Medicine Korea PK0242
03: IBD: Clinical - Treatment and Prognosis EP-087 Baseline Plasma Proteomics Predicts Natural Disease Course Progression in Treatment-Naive Crohn's Disease Yu Wang The First Affiliated Hospital of Sun Yat-sen University, Zhongnan hospital of wuhan university China PF0387
03: IBD: Clinical - Treatment and Prognosis EP-088 Non-Alcoholic Fatty Liver Disease as an Independent Risk Factor for Poor Biologic Therapy Outcomes and Increased Adverse Events in Crohn's Disease: A Retrospective Cohort Study Shengdi Zhang Xiangya Hospital, Central South University China OF0375
03: IBD: Clinical - Treatment and Prognosis EP-089 Real-World Effectiveness and Safety of Etrasimod in Ulcerative Colitis: Interim Analysis of the EFFECT-UC Study Michelle Segovia Pfizer Inc United States PF0214
03: IBD: Clinical - Treatment and Prognosis EP-090 Long-Term Etrasimod Efficacy in Patients with Ulcerative Colitis Stratified by Prior Biologic/JAKi Experience: 2-Year Outcomes from the ELEVATE UC OLE Michelle Segovia Pfizer Inc United States PF0199
03: IBD: Clinical - Treatment and Prognosis EP-091 Impact of Concomitant Immunomodulator Use by UST-CDST Classification on Clinical Relapse in Crohn's Disease Patients Treated with Ustekinumab: A Multicenter Study Jongbeom Shin Inha university hospital, Inha University School of Medicine Korea OK0018
03: IBD: Clinical - Treatment and Prognosis EP-092 Preoperative Cellularity-Scale Diffusion MRI for Risk Stratification of Postoperative Anastomotic Recurrence in Crohn's Disease Qiaochu Zhao The First Affiliated Hospital of Sun Yat-sen University China PF0268
03: IBD: Clinical - Treatment and Prognosis EP-093 Comparative Effectiveness and Safety of Risankizumab vs Ustekinumab in Crohn's Disease: A Real-World Retrospective Cohort Study from Taiwan Ming-Jung Meng Linkou Chang Gung Memorial Hospital., Taiwan Association for the Study of Intestinal Diseases (TASID), Chang Gung Inflammatory Bowel Disease Center Taiwan PF0023
03: IBD: Clinical - Treatment and Prognosis EP-094 Disease Clearance with Etrasimod in Asian Patients with Moderately to Severely Active Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 ENLIGHT UC Trial Xiang Gao The Sixth Affiliated Hospital of Sun Yat-sen University China PF0379
03: IBD: Clinical - Treatment and Prognosis EP-095 Dose Intensification Versus Switching Therapy for Secondary Loss of Response to Infliximab in Crohn's Disease: A Real-World Comparative Study Tong Li First affiliated hospital of Dalian medical university China OF0385
03: IBD: Clinical - Treatment and Prognosis EP-096 Ten-Year Trends in Steroid Use and Barriers to Achieving Treat-to-Target in Inflammatory Bowel Disease: A Real-World Longitudinal Study Jung Hyun Noh Seoul National University Bundang Hostpial, Seoul National University College of Medicine, Chung-Ang University Gwangmyeong Hospital Korea PF0334
03: IBD: Clinical - Treatment and Prognosis EP-097 A Real-World Application Pattern and Efficacy of Ustekinumab (UST) in Crohn's Disease (CD) Based on Physician Assessment Yuanyuan Long Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology China OF0267
03: IBD: Clinical - Treatment and Prognosis EP-098 Granulomatous Inflammation as an Independent Predictor of Secondary Loss of Response to TNF-alpha Inhibitors in Crohn's Disease: A Long-Term Cohort Study Eunjoo Kim Seoul national university Bundang hospital Korea PK0090
03: IBD: Clinical - Treatment and Prognosis EP-099 Improved Pregnancy Outcomes in Crohn's Disease in the Biologic Era: A Single-Center Retrospective Study Minako Sako Tokyo Yamate Medical Center Japan PF0078
03: IBD: Clinical - Treatment and Prognosis EP-100 Drug Persistence and Safety of Biologic Therapy in Inflammatory Bowel Disease: A Real-World Analysis from the TSIBD Registry Chih-Wen Huang Changhua Christian Hospital Taiwan PF0038
03: IBD: Clinical - Treatment and Prognosis EP-101 Efficacy of Guselkumab for Small Bowel Lesions Using Balloon Assisted Enteroscopy: A Phase 3, Open-Label, Multicenter Study Teppei Omori Kyorin University Suginami Hospital, Kyorin University School of Medicine Japan PF0066
03: IBD: Clinical - Treatment and Prognosis EP-102 Development of Predictive Models for Optimized Intravenous Ustekinumab Therapy in Real-World Patients with Crohn's Disease Yuanyuan Long Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology China OF0266
03: IBD: Clinical - Treatment and Prognosis EP-103 Combination Therapy with Biologics or Small-Molecules for Inflammatory Bowel Disease: A Case Series and Meta-Analysis Zihan Chen The First Affiliated Hospital, Sun Yat-sen University China OF0430
03: IBD: Clinical - Treatment and Prognosis EP-104 Pooled Colectomy Rates Following Upadacitinib Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative Colitis: A Systematic Review and Meta-Analysis of Real-World Studies Winston Christopher Wiweko Atma Jaya Catholic University of Indonesia Indonesia OF0198
03: IBD: Clinical - Treatment and Prognosis EP-105 Clinical Characteristics and Treatment Patterns of Ustekinumab in Korean Patients with Crohn's Disease: Subgroup Analysis from a Prospective Nationwide KSTAR Study Byunk Ik Jang Yeungnam University College of Medicine Korea PK0318
03: IBD: Clinical - Treatment and Prognosis EP-106 Clinical Effectiveness of Vedolizumab in Chinese Patients with Ulcerative Colitis: Final Results from the VALUE, a Multicenter Prospective Study Fang Zhou Takeda (China) Holdings Co., Ltd. China OF0077
03: IBD: Clinical - Treatment and Prognosis EP-107 Vedolizumab Demonstrated Significant Improvements in Symptomatic Relief and Quality of Life in Patients with Crohn's Disease: Results from VALUE, a Prospective, Multicenter, Observational Study Xiaoyu Qian Takeda (China) Holdings Co., Ltd. China OF0072
03: IBD: Clinical - Treatment and Prognosis EP-108 Combination of Vedolizumab and Short-Course Infliximab in the Treatment of Crohn's Disease in Induction Remission Period: A Single-Center Real-World Retrospective Analysis Hongxue Lu Department of Gastroenterology, Hunan International Scientific and Technological Cooperation Base of Artificial Intelligence Computer-Aided Diagnosis and Treatment for Digestive Disease, Gut-Liver Axis and Intestinal Barrier Research Center China OF0411
03: IBD: Clinical - Treatment and Prognosis EP-109 Long-Term Clinical Outcomes of Thiopurine Therapy According to NUDT15 Genotype in Ulcerative Colitis Ji Young Chang Ewha Womans University Seoul Hospital Korea PK0345
03: IBD: Clinical - Treatment and Prognosis EP-110 Efficacy and Safety of a Bridging Regimen with Corticosteroids, Oral/Rectal 5-ASA, and Oral Vancomycin Prior to Biologic Therapy in Acute Severe Ulcerative Colitis Ping An Wuhan university,renmin hospital China OF0290
03: IBD: Clinical - Treatment and Prognosis EP-111 Etrasimod for the Treatment of Ulcerative Colitis: Up to 5 Years of Safety Data from the Global Clinical Program Ken Takeuchi Tsujinaka Hospital Kashiwanoha Japan PF0209
03: IBD: Clinical - Treatment and Prognosis EP-112 Tulisokibart in Patients with Moderately to Severely Active Crohn's Disease: Efficacy and Safety Through Week 146 from the Phase 2 APOLLO-CD Study Rupert W. Leong Concord Hospital Australia PK0118
03: IBD: Clinical - Treatment and Prognosis EP-113 Three Year Efficacy and Safety of Mirikizumab Treatment in Chinese Patients with Crohn's Disease: A Subpopulation Analysis from the VIVID-2 Extension Study Qian Cao Sir Run Run Shaw Hospital, China China OF0306
03: IBD: Clinical - Treatment and Prognosis EP-114 Relationship Between Clinical and Histologic Findings with Tulisokibart Induction at Week 12 and Maintenance Dosing at Week 50 in the Randomized Controlled ARTEMIS-UC Study in Participants with Ulcerative Colitis Rupert Leong Macquarie University Australia PK0098
03: IBD: Clinical - Treatment and Prognosis EP-115 Sustained Symptomatic Relief and Disease Clearance Through 50 Weeks of Treatment with Tulisokibart in Participants with Moderately to Severely Active Ulcerative Colitis in the Phase 2 ARTEMIS-UC Study Jin Oh Kim MSD AP Region Korea PK0084
03: IBD: Clinical - Treatment and Prognosis EP-116 A Phase Ib Study of TQH3906 Capsule for the Induction Therapy of Moderate to Severe Active Ulcerative Colitis Yani Yin Xiangya Hospital Of Central South University China PF0055
03: IBD: Clinical - Treatment and Prognosis EP-117 Symptomatic Improvement with Intravenous Guselkumab Induction Therapy Is Observed Early in Patients with Moderately to Severely Active Ulcerative Colitis: Post-Hoc Analysis of QUASAR Masayuki Saruta The Jikei University School of Medicine Japan PF0063
03: IBD: Clinical - Treatment and Prognosis EP-118 Impact of Cytomegalovirus Infection on Rescue Therapy in Acute Severe Ulcerative Colitis: A Prospective Multicenter Korean Cohort Sung-Ju Bang Chonnam National University Hospital, Chonnam National University School Korea PK0393
03: IBD: Clinical - Treatment and Prognosis EP-119 Risk Factors for Intestinal Surgery and the Impact of Early Postoperative Biologic Therapy in Crohn's Disease Byung Chul Jin Jeonbuk National University Korea OK0050
03: IBD: Clinical - Treatment and Prognosis EP-120 Long-Term Clinical Outcomes and Prognostic Factors in Crohn's Disease with Internal Fistulas Woo Suji Severance Hospital Yonsei University College of Medicine Korea PK0348
03: IBD: Clinical - Treatment and Prognosis EP-121 Ustekinumab Offers an Effective Treatment Option for Chinese Patients with Moderately to Severely Active Crohn's Disease Xiaoou Li Janssen Research & Development, LLC China OF0055
03: IBD: Clinical - Treatment and Prognosis EP-122 Use of Carotegrast Methyl in 15 Patients with Ulcerative Colitis: A Single-Center Experience Kentaro Onishi Aichi medical university hospital Japan PF0139
03: IBD: Clinical - Treatment and Prognosis EP-123 Machine Learning-Based Prediction of Surgery in Stricturing Crohn's Disease Haluk Tarik Kani Marmara University School of Medicine Türkiye OF0383
03: IBD: Clinical - Treatment and Prognosis EP-124 Acute Severe Ulcerative Colitis (ASUC) Management in a Southeast Asian Tertiary Hospital: Low Prognostic Scores but High Rescue Therapy Use Jonathan Koh Tan Tock Seng Hospital Singapore PF0275
03: IBD: Clinical - Treatment and Prognosis EP-125 Real-World Comparison of Four-Year Outcomes in Patients with Crohn's Disease Treated with Vedolizumab Versus Infliximab Masayuki Fukata JCHO Tokyo Yamate Medical Center Japan OF0034
03: IBD: Clinical - Treatment and Prognosis EP-126 Analysis of Risk Factors for Improvement of Intestinal Mucosa in Patients with Moderate to Severe Crohn's Disease After Treatment with Ustekinumab Hongyan Li The First Hospital of Jilin University China OF0330
03: IBD: Clinical - Treatment and Prognosis EP-127 Physician Opinions on Treatment Preferences and Long-Term Treatment Goals in Moderate to Severe Ulcerative Colitis in China Xiaoxiao Alice Lu Johnson & Johnson Innovative Medicine United States PF0197
03: IBD: Clinical - Treatment and Prognosis EP-128 Early Mucosal Healing and Risk of Proximal Extension in Ulcerative Proctitis: A Single-Center Retrospective Cohort Study Tetsuya Shiraishi Hyogo Medical University Hospital Japan OF0189
03: IBD: Clinical - Treatment and Prognosis EP-129 Physicians' Treatment Preferences and Long-Term Treatment Goals in Ulcerative Colitis and Crohn's Disease: Insights from Physician Surveys in Japan and China Xiaoxiao Alice Lu Johnson & Johnson Innovative Medicine United States PF0228
03: IBD: Clinical - Treatment and Prognosis EP-130 A Comparison of the Efficacy and Safety of Ustekinumab and Upadacitinib in Biologically Experienced Ulcerative Colitis Patients Fehmi Ates Mersin University Medical Faculty Türkiye PF0121
03: IBD: Clinical - Treatment and Prognosis EP-131 Physician Opinions on Treatment Preferences and Long-Term Treatment Goals in Moderate to Severe Ulcerative Colitis and Crohn's Disease in Japan Katsuyoshi Matsuoka Toho University Sakura Medical Center Japan PF0119
03: IBD: Clinical - Treatment and Prognosis EP-132 Treatment Patterns and Medication Adherence in Older Adults with Mild-to-Moderate Ulcerative Colitis: A Multicenter, Comparative, Real-World Study He Gu Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, Inflammatory Bowel Disease Research Center;Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai Institute of Digestive Disease, NHC Key Laboratory of Digestive Diseases China OF0397
03: IBD: Clinical - Treatment and Prognosis EP-133 Clinical Outcomes and Mucosal Healing of Carotegrast Methyl in an IBD Clinic Toshihide Ohmori Ohmori Toshihide GI Clinic Japan OF0114
03: IBD: Clinical - Treatment and Prognosis EP-134 Subcutaneous Infliximab (CT-P13 SC) as Maintenance Therapy for Crohn's Disease in Japan: Safety and Efficacy over 44 Weeks Ken Takeuchi Tsujinaka Hospital Kashiwanoha Japan PK0095
03: IBD: Clinical - Treatment and Prognosis EP-135 Efficacy and Tolerability of Amitriptyline in Mild-to-Moderate Ulcerative Colitis: A Double-Blind Randomized Placebo-Controlled Trial Amitkumar Chavan All India Institute of Medical Sciences India OF0245
03: IBD: Clinical - Treatment and Prognosis EP-136 Comparative Efficacy of Structured Dietary Therapies and Fasting Protocols for the Induction of Remission in Adult Crohn's Disease: A Systematic Review and Network Meta-Analysis Rahul Falodia All India Institute of Medical Sciences, Jodhpur India OF0349
03: IBD: Clinical - Treatment and Prognosis EP-137 Treatment Pathway of Advanced Therapies in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Cohort Study in Korea Hyoung Il Choi Kyung Hee University Hospital at Gangdong, Kyung Hee University College of Medicine Korea PK0350
03: IBD: Clinical - Treatment and Prognosis EP-138 Recapturing Disease Control with Subcutaneous Infliximab After a Drug Holiday Following Intravenous Infliximab Induction: A Post Hoc Analysis of LIBERTY-CD and -UC Studies Noehyun Myung Celltrion Inc. Korea PK0173
03: IBD: Clinical - Treatment and Prognosis EP-139 Impact of up to 3 Years of Continuous Etrasimod Treatment: Long-Term Efficacy Results from the ELEVATE UC Open-Label Extension Ken Takeuchi Tsujinaka Hospital Kashiwanoha Japan PF0196
03: IBD: Clinical - Treatment and Prognosis EP-140 Poor Adherence to International Guidelines for Preventing Post-Operative Recurrence in Crohn's Disease in an Australian Tertiary Centre Damjana Bogatic The Queen Elizabeth Hospital Australia PF0416
03: IBD: Clinical - Treatment and Prognosis EP-141 Efficacy of Etrasimod in Ulcerative Colitis Patients Previously Treated with 5-Aminosalicylates and/or Thiopurines: Post Hoc Results from the Phase 3 ENLIGHT UC Study Xiang Gao The Sixth Affiliated Hospital of Sun Yat-sen University China PF0377
03: IBD: Clinical - Treatment and Prognosis EP-142 Short-Term Effectiveness of Mirikizumab in Crohn's Disease Patients with Perianal Involvement Masayuki Fukata JCHO Tokyo Yamate Medical Center Japan OF0078
03: IBD: Clinical - Treatment and Prognosis EP-143 Early Introduction of Advanced Therapy in Crohn's Disease with Perianal Fistula According to the Hughes Classification: A Single-Center Retrospective Study Tsutomu Masuda Ikoma Sakura Clinic Japan PF0114
03: IBD: Clinical - Treatment and Prognosis EP-144 Clinical Characteristics, Treatment Patterns and Outcomes of Refractory Hospitalized Patients with Inflammatory Bowel Disease: A Single-Center Retrospective Cohort Study from China Fan Zhang Shanghai Tenth People's Hospital, School of Medicine, Tongji University China PF0103
03: IBD: Clinical - Treatment and Prognosis EP-145 Long-Term Treatment Persistence of Vedolizumab in Ulcerative Colitis: Impact of Age at Disease Onset - a Retrospective Study Masatsugu Sato Tsujinaka Hospital Kashiwanoha Japan PF0421
03: IBD: Clinical - Treatment and Prognosis EP-146 Difficult-to-Treat Inflammatory Bowel Disease: Experience of a Single Medical Center Tsui-Chun Hsu Changhua Christian Hospital Taiwan PF0085
03: IBD: Clinical - Treatment and Prognosis EP-147 Effectiveness and Safety of Upadacitinib in Patients with Crohn's Disease and Ulcerative Colitis: A Korea Multicenter Retrospective Cohort Study Won-Hee Lee Chosun university Korea PK0418
03: IBD: Clinical - Treatment and Prognosis EP-148 Filgotinib After Initial Systemic Steroid Therapy Demonstrated Non-Inferiority to Steroid Re-Escalation for 3-Month Steroid Free Status in Ulcerative Colitis: A Japanese Claims Database Study Masayuki Saruta The Jikei University School of Medicine Japan OF0117
03: IBD: Clinical - Treatment and Prognosis EP-149 Drug Persistence of Ustekinumab in Patients with Inflammatory Bowel Disease: Findings from the Multicenter Taiwan Real-World Study Shih-Hua Lin New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation) Taiwan PF0070
03: IBD: Clinical - Treatment and Prognosis EP-150 Vedolizumab and Upadacitinib in Combination as Salvage Therapy for Anti-TNF-alpha Refractory Crohn's Disease Xiaomin Sun Shanghai Tenth People's Hospital Affiliated with Tongji University China PF0050
03: IBD: Clinical - Treatment and Prognosis EP-151 How to Evaluate the Long-Term Therapeutic Effects of Biologics? Yu Peng Xiangya Hospital of Central South University China OF0405
03: IBD: Clinical - Treatment and Prognosis EP-152 Does Extent of Disease Affect Outcomes in Ulcerative Patients on Advanced Therapy? A Real World Study from Singapore Jonas Ho Singhealth Singapore PF0047
03: IBD: Clinical - Treatment and Prognosis EP-153 One-Year Real-World Effectiveness and Tolerability of Adjunctive Oral Calcium Butyrate in Inflammatory Bowel Disease: A Retrospective Cohort Tarkan Karakan Gazi University Faculty of Medicine Türkiye OF0351
03: IBD: Clinical - Treatment and Prognosis EP-154 Guselkumab for Active Crohn's Disease: Efficacy and Safety Outcomes at Week 12 in a Prospective Cohort Study Jiayin Yao The Sixth Affiliated Hospital of Sun Yat-Sen University China PF0274
03: IBD: Clinical - Treatment and Prognosis EP-155 The Role of Immunosuppressant Agents in the Era of Anti-TNF and Non-Anti-TNF Biologics for Inflammatory Bowel Disease: Multicenter Study from the TSIBD Registration Tzu-Wen Chen MacKay Memorial Hospital Taiwan PF0181
03: IBD: Clinical - Treatment and Prognosis EP-156 Clinical Outcomes of Long-Term Infliximab Treatment for 15 Years in Patients with Crohn's Disease: A Retrospective Study Zihan Chen The First Affiliated Hospital, Sun Yat-sen University China OF0425
03: IBD: Clinical - Treatment and Prognosis EP-157 Clinical Effectiveness of Vedolizumab in Chinese Patients with Crohn's Disease: Final Results from VALUE, a Multicenter Prospective Study Xiaoyu Qian Takeda (China) Holdings Co., Ltd. China PF0056
03: IBD: Clinical - Treatment and Prognosis EP-158 Spectrum of IBS Symptoms in Ulcerative Colitis Patients in Remission Nitin R Professor and HOD India OF0291
03: IBD: Clinical - Treatment and Prognosis EP-159 The Safety of Vedolizumab in the Management of Chinese Patients with Inflammatory Bowel Disease: Findings from a Multicenter, Prospective, Observational, VALUE Study Xiaoyun Qian Takeda (China) Holdings Co., Ltd. China OF0070
03: IBD: Clinical - Treatment and Prognosis EP-160 Short-Term Efficacy of Risankizumab and Ustekinumab for Fistulizing Crohn's Disease: A Real-World Cohort Study in Taiwan Ching-Huang Su Chang Gung Memorial Hospital Taiwan PF0122
03: IBD: Clinical - Treatment and Prognosis EP-161 Ustekinumab as First Line Biologic in Indian Patients with Moderate to Severe Crohn's Disease: Safety and Efficacy from a Multicentre Phase IV Study Gourdas Choudhuri Fortis Memorial Research Institute India PF0358
03: IBD: Clinical - Treatment and Prognosis EP-162 Temporal Trends in Clinical Outcomes of Ulcerative Colitis Stratified by Cytomegalovirus Status Across Three Successive Therapeutic Eras Hiroki Kitamoto Kyoto University Hospital Japan PF0347
03: IBD: Clinical - Treatment and Prognosis EP-163 Caloric Restriction During Hospitalization Is Associated with Improved Mucosal Healing in Patients with Ulcerative Colitis Tomoyuki Nagai Kindai University Japan OF0307
03: IBD: Clinical - Treatment and Prognosis EP-164 Impact of Ileocecal Resection on Quality of Life in Patients with Crohn's Disease: A Cross-Sectional Study Jueon Hong Asan Medical Center Korea PK0223
03: IBD: Clinical - Treatment and Prognosis EP-165 Efficacy of Guselkumab in Moderately to Severely Active Ulcerative Colitis by Extent of Disease and Inflammatory Burden: Subgroup Analysis of the Phase 3 QUASAR Maintenance Study Tadakazu Hisamatsu Kyorin University Japan PF0067
03: IBD: Clinical - Treatment and Prognosis EP-166 Effect of Proton Pump Inhibitor Versus Potassium Competitive Acid Blocker for Clinical Course of Ulcerative Colitis Kwang Woo Kim Seoul Metropolitan Government - Seoul National University Boramae Medical Center, Seoul National University College of Medicine Korea PK0383
03: IBD: Clinical - Treatment and Prognosis EP-167 Efficacy and Safety of Tulisokibart Maintenance Treatment in Induction Responders vs Reinduction and Delayed Induction Responders: Results from the Phase 2 ARTEMIS-UC Trial Open-Label Extension in Participants with Ulcerative Colitis Jin Oh Kim MSD AP Region Korea PK0101
03: IBD: Clinical - Treatment and Prognosis EP-168 The Baseline Nutritional Risk Negatively Affects Clinical and Radiological Remission of Perianal Fistulizing Crohn's Disease: A Dual-Center, Propensity Score Analysis Mengfan Chen The Tenth People's Hospital affiliated to Tongji University China PF0100
03: IBD: Clinical - Treatment and Prognosis EP-169 Real-World Comparative Effectiveness of Ferric Carboxymaltose and Iron Sucrose for Iron Deficiency Anemia in Inflammatory Bowel Disease Jeong Hwa Lee Asan Medical Center, University of Ulsan College of Medine, Kyungpook National Universtiy Hospital Korea PK0075
03: IBD: Clinical - Treatment and Prognosis EP-170 The Importance of Endoscopic Surveillance in Ulcerative Colitis Patients with Primary Sclerosing Cholangitis Mio Namikawa Kyoto University Graduate School of Medicine Japan PF0029
03: IBD: Clinical - Treatment and Prognosis EP-171 A Study on Predicting the Mucosal Healing Ability of Infliximab Induction Therapy for Crohn's Disease. Chen Ruidong The Second Affiliated Hospital of Soochow University, The First Affiliated Hospital with Nanjing Medical University China OF0206
03: IBD: Clinical - Treatment and Prognosis EP-172 Mucosa Healing in Bio-Naive and Bio-Exposed Patients with Ulcerative Colitis Receiving Ustekinumab Monotherapy and in Combination with Mesalazines Oleg Knyazev Moscow Clinical Center named after A.S. Loginov Russian Federation OF0017
03: IBD: Clinical - Treatment and Prognosis EP-173 Vedolizumab Demonstrated Effectiveness in Improving Symptom Relief and Quality of Life in Chinese Patients with Ulcerative Colitis: Results from the Real-World VALUE Study Fang Zhou Takeda (China) Holdings Co., Ltd. China OF0071
03: IBD: Clinical - Treatment and Prognosis EP-174 Outcomes of Early Versus Delayed Advanced Therapy Initiation in Patients with Ulcerative Colitis: A Multicenter Retrospective Study Hongsub Lee Busan Paik Hospital, Inje University College of Medicine Korea PK0236
03: IBD: Clinical - Treatment and Prognosis EP-175 Superior Efficacy of Vedolizumab over Infliximab in ANCA-positive Patients with Moderately to Severely Active Ulcerative Colitis: A Prospective Cohort Study An Ping Renmin Hospital of Wuhan University China OF0231
03: IBD: Clinical - Treatment and Prognosis EP-176 A Real-World Study on Psychiatric Adverse Events Induced by Biologics for Inflammatory Bowel Disease Chong Pan People's Hospital of Xinjiang Uygur Autonomous Region China PF0276
03: IBD: Clinical - Treatment and Prognosis EP-177 TLR5 Deficiency Promotes Gut Microbiota Dysbiosis and Increases Susceptibility to Colon Inflammation Yihan Huang Tianjin Medical University General Hospital China OF0408
03: IBD: Clinical - Treatment and Prognosis EP-178 The Efficacy of Dual-Targeted Therapy in Patients with Crohn's Disease Oleg Knyazev GBUZ Moscow Clinical Scientific Center named after Loginov MHD Russian Federation PF0198
03: IBD: Clinical - Treatment and Prognosis EP-179 Achieving Mucosal Healing in Patients with Mild-to-Moderately Active Ulcerative Colitis with Oral Mesalazine Bolette Christophersen Ferring Pharmaceuticals A/S Denmark PF0093
03: IBD: Clinical - Treatment and Prognosis EP-180 Effectiveness of Add-on Upadacitinib in Advanced Combination Therapy for Refractory Inflammatory Bowel Disease: A Retrospective Cohort Study in Taiwan Shih-Hua Lin New Taipei Municipal TuCheng Hospital (Built and Operated by Chang Gung Medical Foundation) Taiwan PF0069
03: IBD: Clinical - Treatment and Prognosis EP-181 Restarting Etrasimod After Treatment Interruption Is Not Associated with Cardiovascular Events: Analysis from the ELEVATE UC Clinical Program Michelle Segovia Pfizer Inc United States PF0194
03: IBD: Clinical - Treatment and Prognosis EP-182 Two-Year Clinical Outcomes of Upadacitinib Maintenance Therapy in Patients with Ulcerative Colitis Hiroyuki Tamaki Takamatsu Red Cross Hospital Japan OF0120
03: IBD: Clinical - Treatment and Prognosis EP-183 FXR-Mediated NLRP3 Inflammasome Regulation Modulates Macrophage Pyroptosis During Ulcerative Colitis Pathogenesis Yaling Gan Wuxi People's Hospital of Nanjing Medical University China PF0045
03: IBD: Clinical - Treatment and Prognosis EP-184 Guselkumab Maintenance Dose Regimens in Patients with High Disease Activity and Severity: Subgroup Analysis of Participants with Moderately to Severely Active Crohn's Disease in the GALAXI Phase 3 Studies Keira Herr Johnson & Johnson Asia Pacific Singapore PF0043
03: IBD: Clinical - Treatment and Prognosis EP-185 Combined Advanced Therapies in Patients with Inflammatory Bowel Disease in Thailand: Prescribing Patterns and Clinical Outcomes Thanaboon Chaemsupaphan Siriraj Hospital, Mahidol University Thailand PF0212
03: IBD: Clinical - Treatment and Prognosis EP-186 Prognostic Risk Assessment in Ulcerative Colitis Based on Multivariate Regression and Qualitative Comparative Analysis Shichen Zhu Zhejiang University School of Medicine China PF0338
03: IBD: Clinical - Treatment and Prognosis EP-187 Machine Learning for Predicting Secondary Non-Response of Infliximab Treatment in Crohn's Disease: A Single-Center Retrospective Study Lingya Xiang Chongqing, China. China PF0190
03: IBD: Clinical - Treatment and Prognosis EP-188 Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis Mohamed Hamouda Elkasaby Faculty of Medicine, Al-Azhar University Egypt OF0402
03: IBD: Clinical - Treatment and Prognosis EP-189 Real World Effectiveness and Safety of Vedolizumab in the Treatment of Patients with Ulcerative Colitis: The Updated Data from Our Single Center Study Cui Zhang Tongji university China PF0210
03: IBD: Clinical - Treatment and Prognosis EP-190 Retrospective Study of Cases After Induction Therapy with Tacrolimus in Our Hospital Yasuhisa Murai Hirosaki University, Graduate School of Medicine, Hirosaki University Hospital Japan OF0337
03: IBD: Clinical - Treatment and Prognosis EP-192 Infectious Complications in Hospitalized Patients with Inflammatory Bowel Disease and Associated Risk Factors Lth Thu Thai Nguyen University Of Medicine And Pharmacy Vietnam PF0278
03: IBD: Clinical - Treatment and Prognosis EP-193 Characteristics of Anemia and Response to Iron Therapy in Patients with Inflammatory Bowel Disease: A Single-Center Study in Vietnam Lth Thu Thai Nguyen University Of Medicine And Pharmacy Vietnam PF0129
03: IBD: Clinical - Treatment and Prognosis EP-194 Upadacitinib in Inflammatory Bowel Disease: Single Center Experience Filiz Akyuz Istanbul University Istanbul Faculty of Medicine Türkiye OF0159
03: IBD: Clinical - Treatment and Prognosis EP-195 Real-World Use of Concomitant Immunomodulators with Biologics in Patients with Inflammatory Bowel Disease Wei-Chen Lin Mackay Memorial Hospital Taiwan PF0025
03: IBD: Clinical - Treatment and Prognosis EP-196 Effectiveness of Ustekinumab Maintenance Therapy Administered Every 12 Weeks in Patients with Moderate-to-Severe Ulcerative Colitis Kohei Sugiyama Sapporo IBD Clinic, Sapporo Central Hospital Japan PF0261
03: IBD: Clinical - Treatment and Prognosis EP-197 Early Clinical Improvement with Upadacitinib in Moderate-to-Severe Ulcerative Colitis, Including Refractory Cases: Implications for Week-4 Treatment Decision- a Single-Center Experience Yukako Komori Kitasato University School of Medicine Japan PF0193
03: IBD: Clinical - Treatment and Prognosis EP-198 Quantifying the Benefits of Full Dose Time-Dependent Mesalazine for the Induction and Maintenance of Remission in Mild-to-Moderate Ulcerative Colitis in Adults: A Systematic Literature Review and Meta-Analysis Bolette Christophersen Ferring Pharmaceuticals A/S Denmark PF0092
03: IBD: Clinical - Treatment and Prognosis EP-199 Pharmacologic and Dietary Interventions for Upper Gastrointestinal Involvement in Crohn's Disease: A Systematic Review Noha Hammad Faculty of Medicine, Port-Said University Egypt OF0407
03: IBD: Clinical - Treatment and Prognosis EP-200 Hemorrhagic Shock Despite Clinical and Endoscopic Improvement with Upadacitinib in Acute Severe Ulcerative Colitis: A Three-Case Series Keita Suzuki Kitasato University Kitasato Institute Hospital, Kitasato University Kitasato Institute Hospital Japan PF0115
03: IBD: Clinical - Treatment and Prognosis EP-201 Clinical Characteristics and Risk Factors Analysis of Recurrence in Inflammatory Bowel Disease Patients with Endoscopic Mucosal Healing Yingzhi Zhang Chongqing General Hospital China OF0265
03: IBD: Clinical - Treatment and Prognosis EP-202 Evaluation of the Rate of Changes, Persistency, and Safety in a Prospective Observational Study Based on Patient-Preferred Selection in Patients with Ulcerative Colitis (VIVSC Study) Shingo Kato Saitama Medical Center, Saitama Medical University Japan PF0065
03: IBD: Clinical - Treatment and Prognosis EP-203 Protective Effects of Statin Therapy on Clinical Outcomes in Inflammatory Bowel Disease: A Propensity Score Matched Analysis Pragya Gautam Territorial manager Nepal PF0017
03: IBD: Clinical - Treatment and Prognosis EP-204 Prevention of Thromboembolic Complications in Patients with Ulcerative Colitis Anna Kagramanova Moscow Clinical Center named after A.S. Loginov Russian Federation PF0016
03: IBD: Clinical - Treatment and Prognosis EP-205 Psychological Support in Patients with Ulcerative Colitis for Adherence to Drug Therapy Oleg Knyazev Moscow Clinical Center named after A.S. Loginov Russian Federation PF0010
03: IBD: Clinical - Treatment and Prognosis EP-206 Mucosal Healing and Outcomes of Pregnancy Oleg Knyazev Moscow Clinical Center named after A.S. Loginov Russian Federation PF0009
03: IBD: Clinical - Treatment and Prognosis EP-207 Can Etrasimod Effectively Treat Ulcerative Colitis-Associated Pyoderma Gangrenosum in an Elderly Patient? Chon Chan Kiang Wu Hospital Macau PF0385
03: IBD: Clinical - Treatment and Prognosis EP-208 Psychological Support in Patients with Ulcerative Colitis to Achieve Steroid-Free Remission Anait Gorodetskaya Moscow Clinical Scientific Center named after A.S. Loginov Russian Federation PF0020
03: IBD: Clinical - Treatment and Prognosis EP-209 Etrasimod in an Elderly Ulcerative Colitis Patient with Pre-Existing Sinus Bradycardia: A Case Report from the ENLIGHT UC Study Zhe Zhang Shengjing Hospital of China Medical University China OF0368
03: IBD: Clinical - Treatment and Prognosis EP-210 Etrasimod in the Treatment of Severe Ulcerative Colitis with Extraintestinal Manifestations: A Case Report from the ENLIGHT UC Study Zhe Zhang Shengjing Hospital of China Medical University China OF0367
03: IBD: Clinical - Treatment and Prognosis EP-211 A Case of Takayasu Arteritis Associated with Ulcerative Colitis in an Elderly Man Kumiko Uchida Gastroenterology Japan PF0412
03: IBD: Clinical - Treatment and Prognosis EP-212 Therapeutic Efficacy and Safety of Fecal Microbiota Transplantation in Ulcerative Colitis: A Systematic Review and Meta-Analysis Noha Hammad Faculty of Medicine, Port-Said University Egypt OF0406
03: IBD: Clinical - Treatment and Prognosis EP-213 Mathematical Modeling of Vedolizumab-Induced Transcriptomic Trajectories Identifies a Bifurcation Point Governing Transition from Transient Response to Durable Remission Failure in Ulcerative Colitis Rifaldy Fajar IMCDS-BioMed Research Foundation Indonesia PF0440
03: IBD: Clinical - Treatment and Prognosis EP-214 Ulcerative Colitis Complicated by Primary Sclerosing Cholangitis and Anti-TNF-Induced Psoriasis: A Case Report Mustafa Kaplan Sultan 2. Abdulhamid Han Training and Research Hospital Türkiye PF0301
03: IBD: Clinical - Treatment and Prognosis EP-215 Biologic Access Restrictions Across Decentralized Provincial Drug Plans Prolong Steroid Dependence and Acute Care Use in Ulcerative Colitis While Integrated Specialist Care Partly Offsets These Harms Aminatus Saadah Telkom University Indonesia PF0425
03: IBD: Clinical - Treatment and Prognosis EP-216 Mucosal Healing Is a Predictor of Favorable Outcomes in Ulcerative Colitis Oleg Knyazev Moscow Clinical Center named after A.S. Loginov Russian Federation PF0011
03: IBD: Clinical - Treatment and Prognosis EP-217 Efficacy of Thiamine for Fatigue in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of RCTs Ahmad Fariz Malvi Zamzam Zein Fatmawati Hospital, Faculty of Medicine, Universitas Swadaya Gunung Jati Indonesia PF0402
03: IBD: Clinical - Treatment and Prognosis EP-218 Effectiveness of Upadacitinib in Bio-Naive Patients with Crohn's Disease: A Case Series Focused on Patient Preference for Oral Therapy and Long-Term Endoscopic Remission Moe Ogawa Kitasato University School of Medicine Japan PF0401
03: IBD: Clinical - Treatment and Prognosis EP-219 A Case of Fistulising Crohn's Disease Complicated with Disseminated Tuberculosis Wilson Wai Shun Cheng Caritas Medical Centre Hong kong, China PF0099
03: IBD: Clinical - Treatment and Prognosis EP-220 Medical Therapy for Ulcerative Colitis Unmasks Sporadic Colorectal Neoplasia: Two Case Reports Sae Nakayama Sagamihara Kyodo Hospital, Kitasato University School of Medicine Japan PF0087
03: IBD: Clinical - Treatment and Prognosis EP-221 Diagnostic Value of Fecal Calprotectin in Differentiating Inflammatory Bowel Disease from Irritable Bowel Syndrome Hk Tien CK Clinic Vietnam PF0277
03: IBD: Clinical - Treatment and Prognosis EP-222 Vedolizumab Achieved Durable Steroid-Free Clinical, Endoscopic, and Histological Remission in Difficult-to-Treat Ulcerative Colitis Refractory to Tofacitinib and Ustekinumab Akira Madarame Tokyo Medical University Japan OF0203
03: IBD: Clinical - Treatment and Prognosis EP-224 Mucosal Healing Becomes Economically Fragile When Copayment Exhaustion and Biologic Supply Failure Disrupt Continuity in Ulcerative Colitis Across Public and Mixed Insurance Systems During Maintenance Therapy Asniah Asniah Agricultural Development Polytechnic Indonesia PF0436
03: IBD: Clinical - Treatment and Prognosis EP-225 The Perfect Storm: Surgical Rescue in Severe Ulcerative Colitis Complicated by CMV and Severe Systemic Infection Ratchanok Suppawat Bhumibol Adulyadej Hospital Thailand PF0097
03: IBD: Clinical - Treatment and Prognosis EP-226 Comparative Efficacy of Advanced Therapies in Fistulizing Crohn's Disease: An Updated Network Meta-Analysis Satinder Singla Kalinga Institute of Medical Sciences, Bhubaneswar India OF0182
03: IBD: Clinical - Treatment and Prognosis EP-441   A Young Cho Severance Hospital, Yonsei University College of Medicine Korea PK0424
04: IBD: Clinical - Intestinal Ultrasound EP-227 Accuracy of the Milan Ultrasound Criteria in Assessing Endoscopic Activity of Ulcerative Colitis Ye Zhao The First Affiliated Hospital of Zhengzhou University China PF0330
04: IBD: Clinical - Intestinal Ultrasound EP-228 Predictive Value of Intestinal Ultrasound Combined with Fecal Calprotectin for the Response to Biologic Therapy in Ulcerative Colitis Wei Chen The 7th Medical Center, Chinese PLA General Hospital China PF0259
04: IBD: Clinical - Intestinal Ultrasound EP-229 Use of Intestinal Ultrasound and Other Imaging Tests in Ulcerative Colitis and Crohn's Disease: Insights from a Japan Physician Survey Katsuyoshi Matsuoka Toho University Sakura Medical Center Japan PF0120
04: IBD: Clinical - Intestinal Ultrasound EP-230 Real-World Experience of the International Bowel Ultrasound Segmental Activity Score for Assessing Disease Activity in Crohn's Disease Arshdeep Singh Dayanand Medical College and Hospital India OF0175
04: IBD: Clinical - Intestinal Ultrasound EP-231 Comparison of Intestinal Ultrasonography (IUS) and Colonoscopy in Assessing Disease Activity and Severity in Ulcerative Colitis Pradip Kafle Tribhuvan university teaching hospital (TUTH) Nepal OF0029
04: IBD: Clinical - Intestinal Ultrasound EP-232 Intestinal Ultrasound Characteristics and Symptom Correlation in Ulcerative Colitis and Non-IBD Colitis: A Comparative Analysis Chih-Wen Huang Changhua Christian Hospital Taiwan PF0215
04: IBD: Clinical - Intestinal Ultrasound EP-233 Bowel Wall Thickness Reduction Following Risankizumab Therapy Assessed by Intestinal Ultrasonography in Crohn's Disease Maki Miyakawa Sapporo IBD Clinic Japan PF0263
04: IBD: Clinical - Intestinal Ultrasound EP-234 Construction and Analysis of an Endoscopic Activity Prediction Model for Ulcerative Colitis Based on Intestinal Ultrasound Combined with Biomarkers Zhexuan Liu Hebei Medical University China PF0216
04: IBD: Clinical - Intestinal Ultrasound EP-235 Monitoring Disease Activity Using Intestinal Ultrasonography in Patients with Ulcerative Colitis Treated with Mirikizumab Masanao Nasuno Sapporo IBD Clinic Japan PF0260
04: IBD: Clinical - Intestinal Ultrasound EP-236 Diagnostic Performance of Intestinal Ultrasound for Disease Activity Assessment in Ulcerative Colitis Chih-Wen Huang Changhua Christian Hospital Taiwan PF0304
04: IBD: Clinical - Intestinal Ultrasound EP-237 Real-World Implementation of Intestinal Ultrasound for IBD Management in a Tertiary Public Hospital in Hong Kong Tsz Fai Cheng Tuen Mun Hospital Hong kong, China PF0171
04: IBD: Clinical - Intestinal Ultrasound EP-238 First Experience of Intestinal Ultrasound for the Diagnosis and Monitoring of Inflammatory Bowel Disease in Mongolia Ariunzul Dashdondog The First Central Hospital of Mongolia Mongolia PF0408
04: IBD: Clinical - Intestinal Ultrasound EP-239 Gut Ultrasound and C-Reactive Protein Discordance Unmasks Silent Ileal Progression in Older Adults with Crohn's Disease, Frailty, and Multimorbidity During Routine Longitudinal Monitoring Nadeem Alam Doha Institute for Graduate Studies Qatar OF0427
04: IBD: Clinical - Intestinal Ultrasound EP-240 TB or Not TB: The Role of Intestinal Ultrasound in Differentiating Intestinal Tuberculosis from Crohn's Disease Hasan Alaali University of Malay Medical center Malaysia PF0356
04: IBD: Clinical - Intestinal Ultrasound EP-241 Personalized Mesh Selection in Laparoscopic Abdominal Wall Hernia Repair in Patients with Inflammatory Bowel Disease Using Machine Learning Rohit Rajput F H Medical College & Hospital India OF0463
05: IBD: Basic / Translational / Microbiome EP-242 Healthy Donor-Derived Alistipes shahii CKDB500 Enhances 5-Aminosalicylic Acid Efficacy by Modulating Host Drug Metabolism and Inflammatory Signaling in Colitis Ye Won Kim Brain Korea 21 Project, Yonsei University College of Medicine Korea OK0392
05: IBD: Basic / Translational / Microbiome EP-243 Single-Cell Profiling of the Spatial Immune Landscape in Pediatric Crohn's Disease: Focus on Rectal Th1 Cytotoxicity Jin Gyu Lim Seoul National University College of Medicine Korea PK0404
05: IBD: Basic / Translational / Microbiome EP-244 Bifidobacterium infantis Derived Extracellular Vesicles Protect Against NSAID-induced Colonic Injury in Colitis Models Hyeon-Jeong Jeon Ewha Womans University College of Medicine Korea OK0146
05: IBD: Basic / Translational / Microbiome EP-245 Spatially Resolved Tumor Heterogeneity and Fibroblast Coupling in Colitis-Associated Colorectal Cancer Yoonho Lee Brain Korea 21 project, Asan Medical Center, University of Ulsan College of Medicine Korea OK0356
05: IBD: Basic / Translational / Microbiome EP-246 Endothelial Cell PTPN14-AHR Axis Maintains the Gut Vascular Barrier to Alleviate Colonic Inflammation Qi Chen Tianjin Medical University General Hospital China OF0219
05: IBD: Basic / Translational / Microbiome EP-247 Bacteroides uniformis Ameliorates Intestinal Fibrosis and Improves Serum Metabolites Profiles in Crohn's Disease Caiguang Liu The First Affiliated Hospital, Sun Yat-sen University China OF0292
05: IBD: Basic / Translational / Microbiome EP-248 F. nucleatum Remodels Glycerophospholipid Metabolism to Activate Immunogenic Intestinal Dendritic Cells in Crohn's Pathogenesis Jiayun Wang The First Affiliated Hospital of Nanjing Medical University China PF0240
05: IBD: Basic / Translational / Microbiome EP-249 Prevotella copri OmpA Associates with VAMP8 in Intestinal Epithelial Cells and Aggravates Ulcerative Colitis Shushan Chen General Hospital, Tianjin Medical University, National Key Clinical Specialty, Tianjin Institute of Digestive Diseases, Tianjin Key Laboratory of Digestive Diseases China PF0363
05: IBD: Basic / Translational / Microbiome EP-250 The Combination of Thalidomide and Azathioprine Synergistically Inhibits T Cell Activation and Proliferation in Crohn's Disease Tong Li First affiliated hospital of Dalian medical university China PF0332
05: IBD: Basic / Translational / Microbiome EP-251 microRNA-21 Knockout Protects Against DSS-Induced Acute Colitis and Is Associated with Distinct Gut Microbiota Composition Jae Gon Lee Hanyang University Guri Hospital Korea PK0322
05: IBD: Basic / Translational / Microbiome EP-252 Distinct Transcriptomic Profiles of Tonsil-Derived and Adipose-Derived Mesenchymal Stem Cells Under Intestinal Stem Cell-Like Differentiation with Implications for IBD Therapy Ju Ran Byeon Ewha Womans University Korea PK0430
05: IBD: Basic / Translational / Microbiome EP-253 Inflammatory and Fibrotic Microenvironments of Mesenteric Adipose Tissue in Crohn's Disease: An Electron Microscopy-Based Analysis Yang Hee Joo Ewha Womans University College of Medicine Korea PK0170
05: IBD: Basic / Translational / Microbiome EP-254 Treatment Effect of Extracellular Vesicles Extracted from Tonsil-Derived Mesenchymal Stem Cells in Murine Colitis Model So Yeon Park Ewha Womans University College of Medicine Korea PK0172
05: IBD: Basic / Translational / Microbiome EP-255 Rapid Gut Microbiota-Associated Lipidome Profiling in Inflammatory Bowel Disease: A Novel Approach for Disease Molecular Characterization and Therapeutic Monitoring Hongsub Lee Busan Paik Hospital, Inje University College of Medicine Korea PK0089
05: IBD: Basic / Translational / Microbiome EP-256 The Role and Mechanisms of SLC6A19 in the Pathogenesis of Ulcerative Colitis Through Regulation of Intestinal Epithelial Barrier Homeostasis Xiaomei Song Chongqing General Hospital China OF0131
05: IBD: Basic / Translational / Microbiome EP-257 Oral Microbiome Diversity and Composition in Inflammatory Bowel Disease Patients with Periodontitis Weiwei Zheng The First Affiliated Hospital, Fujian Medical University China OF0094
05: IBD: Basic / Translational / Microbiome EP-258 Lachnospiraceae Flagellin Ameliorate Ulcerative Colitis and Associated Anxiety Jiaying Jiang Tianjin Medical University General Hospital China OF0416
05: IBD: Basic / Translational / Microbiome EP-259 PAR2 Regulates Colitis in IL-10-deficient Mice by Modulating Pyroptosis and Gut Microbiota Dysbiosis. Geunhyung Yang Pusan national university Korea OK0412
05: IBD: Basic / Translational / Microbiome EP-260 Immune Cell and Microbiota Differences Between the Rectum and Other Colonic Segments in Colitis Weiming Dai Peking University People's Hospital, Peking University People's Hospital China OF0216
05: IBD: Basic / Translational / Microbiome EP-261 ME1-Promoted Macrophage Pyroptosis Influences Intestinal Cell Differentiation and Exacerbates Inflammatory Bowel Disease Huan Zhang The First Affiliated Hospital of Soochow University China PF0064
05: IBD: Basic / Translational / Microbiome EP-262 The Biological and Mechanistic Study of ZNF384-MUC2 Transcriptional Axis to Enhance Intestinal Inflammation Yiqing Yang Xinhua Hospital, Shanghai Jiaotong University School of medicine China PF0255
05: IBD: Basic / Translational / Microbiome EP-263 Mechanistic Study of Branched-Chain Amino Acid Transaminase 1 (BCAT1) in Promoting Macrophage M1 Polarization and Exacerbating Inflammatory Bowel Disease Rufang Dong Department of Gastroenterology, The First Affiliated Hospital of Soochow University, Suzhou, China China PF0266
05: IBD: Basic / Translational / Microbiome EP-264 ROS-Mediated p32 Degradation Drives Goblet Cell Depletion in Imiquimod-Induced Colitis Jeng-Jer Shieh National Chung-Hsing University Taiwan PF0061
05: IBD: Basic / Translational / Microbiome EP-265 Astragalus Polysaccharide Protects Against Intestinal Epithelial Injury in IBD via Inhibiting Cuproptosis in Caco-2 Cells Sihui Zou The First Affiliated Hospital of Soochow University China PF0264
05: IBD: Basic / Translational / Microbiome EP-266 Trojan Horse-Inspired Smart Single-Atom Nanozyme Delivery System for Synergistic Therapy of Inflammatory Bowel Disease Zi Xuan He Changhai Hospital,Naval Medical University China OF0288
05: IBD: Basic / Translational / Microbiome EP-267 AGER Promotes Th1 and Th17 Cell Immune Responses and Intestinal Inflammation Ritian Lin Shanghai East Hospital, Tongji University of School Medicine China PF0128
05: IBD: Basic / Translational / Microbiome EP-268 A Thioredoxin-Defined Redox Signature Stratifies Anaerobe Loss and Dysbiosis in Crohn's Disease Kangrong Zheng The First Affiliated Hospital of Sun Yat-sen University China PF0248
05: IBD: Basic / Translational / Microbiome EP-269 Microbiota-Derived Tryptophan Catabolites Mediate the Chemopreventive Effects of Kushenol A on Ulcerative Colitis Hongsuo Chen General Hospital, Tianjin Medical University, The Second Affiliated Hospital of Baotou Medical College China OF0332
05: IBD: Basic / Translational / Microbiome EP-270 Music Suppresses Intestinal Inflammation as a Novel Histone Methylation Modulator Dong Yan Sir Run Run Shaw Hospital, Zhejiang University School of Medicine China OF0277
05: IBD: Basic / Translational / Microbiome EP-271 DUOX2 Drives Intestinal Inflammation by Orchestrating Epithelial-Macrophage Crosstalk via the APP-CD74 Axis Yalan Xu Peking University People`s Hospital China OF0199
05: IBD: Basic / Translational / Microbiome EP-272 Escin Alleviates the Experimental DSS-Induced Colitis by Remodeling Macrophage Polarization Through NF-?B Signaling Zi-Ru Zhou The Affiliated Wuxi People's Hospital of Nanjing Medical University China OF0024
05: IBD: Basic / Translational / Microbiome EP-273 ZNF267 Attenuates Intestinal Epithelial Inflammation Through TRIM28-dependent SUMOylation Fangyuan Liu Shanghai Jiao Tong University School of Medicine China PF0252
05: IBD: Basic / Translational / Microbiome EP-274 Differential Analysis of Ulcerative Colitis Based on Non-Targeted Metabolomics Wenli Fu People's Hospital of Xinjiang Uygur Autonomous Region China PF0349
05: IBD: Basic / Translational / Microbiome EP-275 Clostridium butyricum Regulates T-Helper 17 Cells-Related Immune Response in Dextran Sodium Sulfate-Induced Colitis Mice by Targeting Toll-Like Receptor 2 Ying Xie Shengjing Hospital of China Medical University China OF0039
05: IBD: Basic / Translational / Microbiome EP-276 Inhibiting JAK/STAT Signaling Promotes Mucosal Homeostasis via Improving Proliferation and Differentiation of Intestinal Epithelial and Stem Cells During Acute Inflammation Runzhao Ma Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology China OF0220
05: IBD: Basic / Translational / Microbiome EP-277 The Environmental-Gut Axis: Cold Adaptation Mitigates IBD Progression via Parallel Ileal Antimicrobial Defense and Colonic Stem Cell Regeneration Yuzhu Di The Second Affiliated Hospital of Harbin Medical University China OF0221
05: IBD: Basic / Translational / Microbiome EP-278 FDPS Regulates Apoptosis and Autophagy of Intestinal Epithelial Cells in Ulcerative Colitis Guangxi Zhou Affiliated Hospital of Jining Medical University China PF0036
05: IBD: Basic / Translational / Microbiome EP-279 DAP12 Deficiency Alleviates Intestinal Inflammation by Regulating Mitochondrial Homeostasis in Macrophages Guangxi Zhou Affiliated Hospital of Jining Medical University China PF0035
05: IBD: Basic / Translational / Microbiome EP-280 Single-Cell Sequencing Analysis of the Interaction Between B Lymphocytes and Regulatory T Cells in Patients with Crohn's Disease. Chuyue Zhong The First Affiliated Hospital of Wenzhou Medical University China OF0273
05: IBD: Basic / Translational / Microbiome EP-281 Epithelial Hypoxia-Inducible Factor 2 Worsen Colitis Through Histone H3K27 Lactylation-Mediated Map3k6 Activation Chen Wang Tianjin Medical University General Hospital China OF0044
05: IBD: Basic / Translational / Microbiome EP-282 Hypoxanthine Aggravates DSS-Induced Colitis and Associated Anxiety/Depressive Behaviors in Mice Ruifang Luo Chongqing General Hospital, Chongqing University, Chongqing, China. China OF0359
05: IBD: Basic / Translational / Microbiome EP-283 Metaproteomics and Crotonylation in Gut Microbial and Its Alterations During Fecal Microbiota Transplantation for the Treatment of Ulcerative Colitis Xin Liu First Affiliated Hospital of Kunming Medical University China PF0204
05: IBD: Basic / Translational / Microbiome EP-284 Single-Cell Sequencing Analysis of Fibroblast Subset Heterogeneity in Inflammatory Bowel Disease Shihao Duan Chongqing General Hospital, Chongqing University China PF0203
05: IBD: Basic / Translational / Microbiome EP-285 Epithelial DUOX2-Driven Oxidative Stress Remodels the Gut Redox Niche to Shape Dysbiosis in Crohn's Disease Rui Feng The First Affiliated Hospital of Sun Yat-sen University China OF0284
05: IBD: Basic / Translational / Microbiome EP-286 Carbon Dots Nanozyme Derived from Atractylodes macrocephala Ameliorates Ulcerative Colitis via Anti-Inflammation, Anti-Oxidation, and Gut Barrier Protection Yifan Li The First Affiliated Hospital of Xi'an Medical University, Shaanxi University of Chinese Medicine China OF0183
05: IBD: Basic / Translational / Microbiome EP-287 Sleep Disturbance as a Factor in Intestinal Inflammation Kohei Kiso Tohoku University School of Medicine Japan PF0138
05: IBD: Basic / Translational / Microbiome EP-288 Cholecystectomy Alleviates Colitis by Reprogramming Macrophage Polarization Through m6A Modification of IRAKM Yang Zhang Peking University People's Hospital China OF0194
05: IBD: Basic / Translational / Microbiome EP-289 The Role and Mechanism of Aerobic Exercise on Improving DSS-induced Intestinal Inflammation by Regulating Mitophagy Through AMPK-SIRT1-FOXO1 Pathway Fang Xiao Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, China OF0210
05: IBD: Basic / Translational / Microbiome EP-290 Remodeling the Apical Brush Border: The TRPV1/ATF3/CALML4 Axis Stabilizes the Intermicrovillar Adhesion Complex and Drives Deep Mucosal Healing in Ulcerative Colitis Yuzhu Di The Second Affiliated Hospital of Harbin Medical University China PF0208
05: IBD: Basic / Translational / Microbiome EP-291 EPS Deficiency Aggravates Intestinal Mucosal Inflammation and Microbiota Disruption Through Restoring Macrophage Polarization Balance in Ulcerative Colitis Fengqin Zhu Affiliated Hospital of Jining Medical University China OF0082
05: IBD: Basic / Translational / Microbiome EP-292 NCF2-associated Macrophage Pyroptosis Is Linked to Anti-TNF Nonresponse in Ulcerative Colitis Xin Gao Shanxi Provincial People's Hospital China OF0318
05: IBD: Basic / Translational / Microbiome EP-293 Genetically Anchored Multi-Omics Prioritizes GPX7 as an SGOC-associated Stromal Regulator in Ulcerative Colitis Xin Gao Shanxi Provincial People's Hospital China OF0316
05: IBD: Basic / Translational / Microbiome EP-294 Metagenomic Characterization of the Gut Microbiota in Ulcerative Colitis Patients from Xinjiang Aizizai Palihati Xinjiang Uygur Autonomous Region People's Hospital China PF0238
05: IBD: Basic / Translational / Microbiome EP-295 Lactobacillus reuteri Protects Against Colitis-Associated Bone Loss by Restoring Gut Barrier Function and Limiting Osteoclastogenesis Liping Liang Guangzhou First People's Hospital, South China University of Technology China OF0380
05: IBD: Basic / Translational / Microbiome EP-296 HMGCS2 Alleviates Ulcerative Colitis by Inhibiting Mitochondrial Apoptosis via Ketone Body Metabolism Wan Yuhong The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan Province, China China PF0136
05: IBD: Basic / Translational / Microbiome EP-297 Commensal Lachnospiraceae bacterium Mitigates Colitis-Induced Mucin Fucosylation Deficits Through ILC3/IL-22 Axis Tianyu Liu Tianjin Medical University General Hospital China OF0056
05: IBD: Basic / Translational / Microbiome EP-298 Metabolic Plasticity in Fusobacterium nucleatum Rewires Sulfur Metabolism to Elevate H2S and Exacerbate Colitis Xiaochen Zhu The First Affiliated Hospital, Sun Yat-sen University China OF0279
05: IBD: Basic / Translational / Microbiome EP-299 Targeting PPAR Signaling-Mediated Lipid Metabolism in Macrophages Attenuates Colitis Xin Wang Tianjin Medical University General Hospital China OF0045
05: IBD: Basic / Translational / Microbiome EP-300 Microbiome Diversity and Taxonomic Differences in Quiescent Ulcerative Colitis: A Comparative Study of Proximal Extension Sung Hoon Jung The Catholic University of Korea Korea PK0438
05: IBD: Basic / Translational / Microbiome EP-301 Therapeutic Effects of Umbilical Cord Mesenchymal Stem Cells on Ulcerative Colitis Qinpei Zhang First Affiliated Hospital of Soochow University China PF0191
05: IBD: Basic / Translational / Microbiome EP-302 Active Targeted Delivery of Magnetic-Driven Micro-Nanorobots Alleviates Ulcerative Colitis by Penetrating Mucus Barrier and Inhibiting Epithelial Ferroptosis Yuzhu Di The Second Affiliated Hospital of Harbin Medical University China PF0213
05: IBD: Basic / Translational / Microbiome EP-303 Octocrylene Aggravates Experimental Colitis Through Epithelial ABCG2 Suppression and Barrier Dysfunction Xin Gao Shanxi Provincial People's Hospital China OF0317
05: IBD: Basic / Translational / Microbiome EP-304 The Role of Aeromonas Species as Enteropathogens in Patients with IBD Daein Kim Department of Internal Medicine, Hallym University Kangdong Sacred Heart Hospital Korea PK0072
05: IBD: Basic / Translational / Microbiome EP-305 Artemisiae Scopariae Herba-Derived Carbon Dot Nanozymes for Targeted Therapy of Ulcerative Colitis Chenye Huang Shaanxi University of Chinese Medicine China PF0175
05: IBD: Basic / Translational / Microbiome EP-306 The Role of PINK1 in Regulating Mitochondrial Homeostasis in Experimental Colitis and Its Underlying Mechanism Dongyan Li Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology China OF0274
05: IBD: Basic / Translational / Microbiome EP-307 HDAC3 Promotes mtDNA Leakage to Activate cGAS/STING Signaling and Worsen Intestinal Barrier Injury in Ulcerative Colitis Yuan Xia West China Hospital, Sichuan University China OF0150
05: IBD: Basic / Translational / Microbiome EP-311 Necroptosis in Inflammatory Bowel Disease: Mechanisms, Immune Amplification, and Therapeutics Wanyu Bao The First Affiliated Hospial of Soochow University China PF0201
06: IBD: Pediatric EP-313 Exploratory Analysis of Vedolizumab Trough Levels in Pediatric-Onset Ulcerative Colitis Tae Jong Jeong Samsung Medical Center Korea OK0439
06: IBD: Pediatric EP-314 Monitoring CT-P17 (Yuflyma) Drug Levels and Remission Rates in Pediatric Crohn's Disease: A Single Center Observational Preliminary Study Yoon Zi Kim Samsung Medical Center Korea OK0441
06: IBD: Pediatric EP-315 Proactive TDM-Guided Infliximab Induction in Pediatric Ulcerative Colitis: Results from a Multicenter Randomized Trial Seon Young Kim Kyung Hee University Hospital, Kyung Hee University College of Medicine Korea OK0418
06: IBD: Pediatric EP-316 Impact of Body Mass Index Changes on Perianal Disease Outcomes in Korean Children with Crohn's Disease: A Retrospective Cohort Study Hansol Kim Samsung Medical Center, Sungkyunkwan University School of Medicine, Pusan National University Children's Hospital, Pusan National College of Medicine Korea OK0404
06: IBD: Pediatric EP-317 Meal Skipping and Micronutrient Depletion Worsen Disease Control in Adolescents with Inflammatory Bowel Disease Through Higher Relapse Burden, Steroid Exposure, and Persistent Nutritional Recovery Gaps over Time Dimas Fajar Prasetyo The University of Western Australia Australia PF0431
06: IBD: Pediatric EP-319 Treatment Withdrawal and Relapse in a Pediatric Patient with Inflammatory Bowel Disease Temuulen Byambadorj National center for Maternal and Child Health Mongolia PF0410
06: IBD: Pediatric EP-320 Distinct Gut Microbiota and Bile Acid Profiles in Pediatric Inflammatory Bowel Disease Versus Functional Gastrointestinal Disorders: Implications for Non-Invasive Differential Diagnosis Xi He Capital Center for Children's Health, Capital Medical University,Capital Institute of Pediatrics China OF0269
07: IBD: Surgery EP-321 Correlation of Colectomy Pathology with Preoperative Colonoscopy in Patients with Inflammatory Bowel Disease Hyun Seok Lee School of Medicine, Kyungpook National University, Virginia Mason Medical Center Korea PK0094
07: IBD: Surgery EP-322 More Severe Natural Course of Crohn's Disease in Yunnan Province Compared with Asian and Western Countries Yan Tao The First Affiliated Hospital of Kunming Medical University China PF0091
08: IBD: Others EP-323 Cognitive, Psychological, and Sleep Impairments in Inflammatory Bowel Disease Yan Liu Chongqing general hospital China OF0095
08: IBD: Others EP-324 Perceptions of Established Nutritional Therapies Among Patients with Crohn's Disease in Korea: A Chungcheong Association for the Study of Intestinal Disease (CHASID) Multicenter Study Kwangwoo Nam Dankook University Hospital Korea PK0303
08: IBD: Others EP-325 Perception and Real-World Practice of Thromboembolism Prophylaxis in Inflammatory Bowel Disease Among Korean Gastroenterologists: A Web-Based National Survey Dae Sung Kim Konyang University College of Medicine Korea PK0327
08: IBD: Others EP-326 S100A8/A9hi Macrophage Activates Intestinal Fibroblast via mCCL6/hCCL15-CCR1 Axis to Drive Intestinal Fibrosis in Crohn's Disease Shu Wang The First Affiliated Hospital with Nanjing Medical University China OF0205
08: IBD: Others EP-327 Clinical Characteristics and Treatment Outcomes of Pyoderma Gangrenosum in Inflammatory Bowel Disease in Korea Ji Yun Oh Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine Korea PK0041
08: IBD: Others EP-328 Clinical Characteristics of Chronic Intestinal Failure in Crohn's Disease Requiring Long-Term Parenteral Nutrition: A 20-Year Experience from a Single Tertiary Center Jung-Bin Park Soonchunhyang University College of Medicine Korea PK0132
08: IBD: Others EP-329 Clinical Characteristics and Disease Outcomes of 5-ASA-Induced Myocarditis in Inflammatory Bowel Disease: A Single-Center Retrospective Small Cohort Study Won Hee Lee College of Medicine, Chosun University Korea PK0317
08: IBD: Others EP-330 Clinical Spectrum and Diagnostic Considerations of Symptomatic Terminal Ileal Lesions: A Retrospective Analysis of 224 Cases Woo Jin Kim Pusan National University Yangsan Hospital Korea PK0346
08: IBD: Others EP-331 A Cost-Effective Novel Diagnostic Method for Detecting Pancreatic Exocrine Insufficiency in Patients with Inflammatory Bowel Disease Mustafa Kaplan Sultan 2. Abdulhamid Han Training and Research Hospital Türkiye PF0297
08: IBD: Others EP-332 Clinical Manifestations, Endoscopic Findings and Outcomes of Cytomegalovirus Colitis in Hospitalized Patients at a Single Tertiary-Care Center Natchaporn Noppacroh Phramongkutklao hospital Thailand PF0265
08: IBD: Others EP-333 The Role and Impact of the Inflammatory Bowel Disease Counsellor: A Qualitative Study on Patient Experiences, Communication Gaps, and Holistic Care Needs Arshia Bhardwaj Dayanand Medical College and Hospital India OF0176
08: IBD: Others EP-334 Tumor Necrosis Factor Alpha Inhibitors Reduce Staged Surgery Rate and Prevent Postoperative Endoscopic Recurrence in Crohn's Disease Patients Xiaomin Sun Shanghai Tenth People's Hospital China PF0073
08: IBD: Others EP-335 Risk Factor Analysis and Risk Assessment Model Development for Crohn's Disease with Metabolic Dysfunction-Associated Fatty Liver Disease in a Chinese Population Xueyun Zhang Baoshan Branch, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University China PF0014
08: IBD: Others EP-336 Assessing Dietary Adequacy and Nutrition Status in Adults with Crohn's Disease Hui-Chuen Chen National Taiwan University Hospital Taiwan PF0320
08: IBD: Others EP-337 Application of the Dual-Factor Model of Mental Health Among Patients with Crohn's Disease in China Shuyan Li The Second Affiliated Hospital, Zhejiang University School of Medicine China PF0267
08: IBD: Others EP-338 Physician Practices and Perceptions of Biosimilar Monoclonal Antibody Use in Inflammatory Bowel Disease: A Real-World Survey Yoo Jin Lee Keimyung University School of Medicine Korea PK0407
08: IBD: Others EP-339 Health-Related Quality of Life in a Southeast Asian Inflammatory Bowel Disease Cohort: A Single-Center Study Jia Hong Koh National University Hospital Singapore OF0126
08: IBD: Others EP-340 Effects of Inflammatory Bowel Diseases on Sexual Functions Fehmi Ates Mersin University Medical Faculty Türkiye PF0229
08: IBD: Others EP-342 Factors Associated with Engagement in a Mini-AppBased Self-Management Platform for IBD Ye Chen Baoshan Branch of Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine China PF0012
08: IBD: Others EP-344 Serum Lipidomics Identifies Altered Lipid Metabolite Levels in Crohn's Disease Lu Wang The First Affiliated Hospital of Ningbo University China OF0458
08: IBD: Others EP-345 A Case of Crohn's Disease Requiring Surgical Resection During Treatment with Ofatumumab for Multiple Sclerosis Yutaro Fujihira Hyogo Medical University Hospital Japan OF0424
08: IBD: Others EP-346 Cytomegalovirus Colitis in Patients with Inflammatory Bowel Disease on Upadacitinib: A Case Series Gary Louie Wollongong hospital Australia PF0343
08: IBD: Others EP-347 Adverse Reactions of Small-Molecule Drugs in the Treatment of Inflammatory Bowel Disease: A Real-World Pharmacovigilance Study Based on the FAERS Database Wei Rao Xinjiang 474 Hospital China PF0313
08: IBD: Others EP-348 Cronkhite-Canada Syndrome: A Case Series of Diverse Outcomes from Complete Remission to Life-Threatening Complications at a Malaysian Tertiary Centre Wah Loong Chan University Malaya Medical Centre Malaysia OF0250
08: IBD: Others EP-349 Semen Discoloration Following Upadacitinib Therapy in Patients with Inflammatory Bowel Disease Jeong Hwa Lee Asan Medical Center, Kyungpook National University Hospital Korea PK0077
08: IBD: Others EP-350 Changes in Body Composition and Prevalence of Sarcopenia in Crohn's Disease. Is There a Link Between Disease Duration, Behaviour, Location, and Severity? Kaushal Kishor Prasad Postgraduate institute of medical education and research India PF0018
08: IBD: Others EP-351 Secondary Amyloidosis Presenting as Nephrotic Syndrome in a Patient with Crohn's Disease: A Rare Extraintestinal Complication. Nitin Rustogi Professor and HOD India PF0106
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-352 Impact of Position Change on Polyp Detection During a Second Look at the Right Colon: A Multicenter, Randomized Controlled Trial Jiyoung Yoon Kangdong Sacred Heart Hospital, Hallym University College of Medicine Korea PK0112
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-353 Characteristics of Colorectal Cancer Detected by Screening Methods in Older Population: A Nationwide Cohort Study Jaeyoon Yeom Yonsei Univ. Wonju College of Medicine Korea PK0326
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-354 Barriers and Willingness for Colorectal Cancer Screening in a Muslim Population of South Asian Country: Nationwide Survey Mian Shah Yousaf Prime Teaching Hospital Pakistan OF0030
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-355 Clinical Predictors of Colorectal Cancer in Patients with Hematochezia Undergoing Colonoscopy: A Retrospective Study in Eastern Indonesia Resha Dermawansyah Rusman Hasanuddin University Indonesia OF0319
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-356 Association Between Metabolic Syndrome and Histological Subtypes of Colorectal Adenomas: A Single-Center Retrospective Study Delgertsog Gantumur Intermed hospital Mongolia OF0310
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-357 Colorectal Cancer Risk in Ulcerative Colitis: A Decade-Long Real-World Cohort from Southern India Kiran Josy Kanjamala Lisie Hospital India OF0381
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-359 Demographic and Metabolic Difference Between Left-Sided Colorectal Cancer (LCRC) and Right-Sided Colorectal Cancer (RCRC) Initially Diagnosed in Health Check Up You Kyoung Lee Healthcare Research Institute, Seoul National University Hospital Healthcare System Gangnam Center Korea PK0378
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-360 Diagnostic Value of i-SCAN with JNET Classification for Predicting Histology of Colorectal Polyps Under 10 mm: A Single-Center Study in Vietnam Dat Le Ba Ho An Binh Hospital Vietnam PF0314
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-361 Serum Trefoil Factor Family 3 as an Effective Biomarker for the Detection of Early Colorectal Cancer Hyun Seok Lee School of Medicine, Kyungpook National University Korea PK0088
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-362 Determinants of Colorectal Cancer Screening Intention Among Russian Adults: The Central Role of Self-Efficacy Iuliia Movsesova Inje University Korea OF0377
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-363 Unusual Presentations of Gastrointestinal Stromal Tumors of Rectum: A Case Series Arvind Ahuja Atal Bihari Vajayee Institute of Medical Science and Dr. Ram Manohar Lohia Hospital India PF0302
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-364 From Bench to Budget: Economic Implications of Colorectal Neoplasia Prevention Across Global Health Systems Fitri Kurnia Universitas Muhammadiyah Sumatera Barat Indonesia PF0217
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-365 Colorectal Neoplasia Screening Collapse After Out-of-Pocket Price Shocks Widens Age and Geographic Inequity, Leaving Older Adults in Peripheral Districts with Lower Uptake and More Advanced Lesions at Diagnosis Irish Merlyn Alvarez National University of Dasmarinas Philippines OF0433
09: Colorectal Neoplasia: Clinical - Epidemiology, Diagnosis and Prevention EP-366 Study on the Correlation Between Histopathological Diagnosis Following Colonic Polypectomy and Adenoma Detection Rate (ADR) Munkhchimeg Damdinsuren General hospital for state special servants Mongolia PF0080
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-367 Optimal Endoscopic Treatment for Rectal Neuroendocrine Tumors, Confirmed After Forceps Biopsy: A Korean Association for the Study of Intestinal Diseases Multicenter, Randomized Non-Inferiority Trial Tae-Geun Gweon College of Medicine, The Catholic University of Korea Korea PK0015
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-368 Comparative Efficacy of Hemoclipping and Snare Tip Soft Coagulation for Prevention of Post-Polypectomy Bleeding: A Chungcheong Association for the Study of Intestinal Disease (CHASID) Multicenter Study Geunhyuk Choi Soonchunhyang University College of Medicine Korea PK0352
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-369 Optimizing Indications and Diagnostic Performance of Computed Tomography Angiography in Acute Gastrointestinal Bleeding: A Large Cohort Study Hye Kyung Hyun Yonsei University College of Medicine, Yongin Severance Hospital Korea PK0076
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-370 The Effectiveness and Safety of Endoscopic Submucosal Dissection for the Treatment of Rectal Gastrointestinal Stromal Tumors: A Pilot Feasibility Study Jae Woong Kim College of Medicine, Chosun University Korea PK0319
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-371 Clinical Characteristics, Treatment Patterns, and Recurrence of Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma: A HASID Multicenter Study Byung Chul Jin Jeonbuk National University Korea PK0305
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-372 Chemotherapy Exposure and Crude Mortality in Early-Onset Colorectal Cancer: A Population-Based SEER Analysis Zavia Putri Salsabila Universitas Islam Indonesia Indonesia OF0195
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-373 Endoscopic Submucosal Dissection of Very Large Early Colorectal Cancer (>4 cm) Kwangwoo Nam Dankook University Hospital Korea PK0310
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-374 Endoscopic Resection for Colorectal Neoplasms in Patients with Ulcerative Colitis Tatyana Savitskaya Ryzhikh National Medical Research Centre for Coloproctology Russian Federation PF0068
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-375 Comparative Clinical Outcomes of Various Colorectal Endoscopic Submucosal Dissection Techniques: A Systematic Review and Network Meta-Analysis Seung Min Hong Pusan National University Hospital Korea PK0336
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-376 Efficacy and Safety of Radiofrequency Ablation for Hemorrhagic Radiation Proctitis: A Retrospective Cohort Study Lingling Xu Affiliated Hospital of Jiangnan University China PF0130
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-377 Effect of Negative Pressure Wound Therapy on Surgical Wound Outcomes in Colorectal Cancer Surgery Patients: A Systematic Review and Meta-Analysis. Mohamed Elkasaby Faculty of Medicine, Al-Azhar University Egypt OF0035
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-378 Rectal Neuroendocrine Tumors Case Report Sugarmaa Purevsuren Central Hospital of MNUMS Mongolia PF0262
10: Colorectal Neoplasia: Clinical - Treatment and Prognosis EP-379 Colonic Tubular Adenocarcinoma Sergelen Shinonmed Sergelen Mongolia PF0053
11: Colorectal Neoplasia: Basic / Translational / Microbiome EP-380 In vitro Immune Prediction Model for Early Tumorigenesis in Lynch Syndrome Using Colon Organoids and Autologous Immune Cells Hyone Hee Lee Yonsei University College of Medicine Korea PK0397
11: Colorectal Neoplasia: Basic / Translational / Microbiome EP-381 Elucidating the Role of CP1-mediated G1/S Cell Cycle Arrest in Colorectal Cancer Cells Sihyun Jeong Pusan National University Korea OK0410
11: Colorectal Neoplasia: Basic / Translational / Microbiome EP-382 MUC13 Expression Is Associated with an Immune-Active Tumor Microenvironment via the KLF4 Axis in Colorectal Cancer. Seung Wook Hong Asan Medical Center, University of Ulsan College of Medicie Korea PK0344
11: Colorectal Neoplasia: Basic / Translational / Microbiome EP-384 Unveiling Cathepsin E: A Key Driver of Colorectal Cancer Progression and Immune Evasion. Huan Zhang The First Affiliated Hospital of Soochow University China PF0386
11: Colorectal Neoplasia: Basic / Translational / Microbiome EP-385 Investigating the Role of a Novel Phosphorylation Site on SOX2 in Colorectal Cancer Dong Keon Kim Institute of Gastroenterology, Severance Hospital, Yonsei University College of Medicine Korea PK0409
11: Colorectal Neoplasia: Basic / Translational / Microbiome EP-386 Uncovering Potential Pro-Carcinogenic Effects of Microplastics in Colonic Polyps and Their Association with Gut Dysbiosis and Intestinal Permeability Dysfunction Dinesh Prasad V Thanga Velu Department of Tissue Engineering and Regenerative Medicine, Faculty of Medicine, National University of Malaysia, 56000, Kuala Lumpur Malaysia OF0147
11: Colorectal Neoplasia: Basic / Translational / Microbiome EP-387 Desulfovibrio vulgaris Flagellin Enhances Metabolite TDA-Driven KDM2A Epigenetic Remodeling to Promote Colorectal Cancer Yadi Lan Tianjin Medical University General Hospital China OF0127
11: Colorectal Neoplasia: Basic / Translational / Microbiome EP-388 DAP12 Promotes Epithelial-Mesenchymal Transition and Tumor Progression in Colitis-Associated Cancer Lihao Shi Affiliated Hospital of Jining Medical University, Shandong University China PF0062
11: Colorectal Neoplasia: Basic / Translational / Microbiome EP-389 AKT1-Centered Multi-Target Mechanisms of Sini Decoction Along the UC and CAC Axis Lihao Shi Affiliated Hospital of Jining Medical University, Shandong University China PF0060
12: Colorectal Neoplasia: Others EP-390 Multi-Omics Identification and Functional Validation of STK17A as a Regulator of TRAIL Sensitivity in Colorectal Cancer Se Lim Kim Research Institute of Clinical Medicine of Jeonbuk National University, Biomedical Research Institute of Jeonbuk National University Hospital Korea PK0232
12: Colorectal Neoplasia: Others EP-391 A Comprehensive Analysis of the Diagnostic Process of Lynch Syndrome in Korea: A 10-Year Retrospective Study at a Tertiary Hospital Jung-Bin Park Soonchunhyang University College of Medicine Korea PK0134
12: Colorectal Neoplasia: Others EP-394 Clinicopathological Features and Modifiable Risk Factors of Colorectal Polyps: A Single-Center Study from Mongolia Suvdantsetseg Borkhuu General hospital of Special State Servants Mongolia PF0174
12: Colorectal Neoplasia: Others EP-395 Endoscopic Resection of a Sigmoid Colon Inflammatory Myofibroblastic Tumor in a Patient with Ulcerative Colitis: A Rare Case Report Delgertsog Gantumur Intermed hospital Mongolia PF0306
13: Small Bowel Disease / Nutritional / Functional Disorder EP-396 Optimizing Clinical Management to Prevent Candidemia in Patients Receiving Total Parenteral Nutrition via Peripherally Inserted Central Catheters: A 10-Year Retrospective Cohort Study Jung Hwan Lee Inha University Hospital, Inha University Hospital Korea PK0353
13: Small Bowel Disease / Nutritional / Functional Disorder EP-397 Altered Serum Microelement Profiles and Their Association with Disease Activity in Taiwanese Patients with Crohn's Disease Tien-Yu Huang Tri-Service General Hospital, National Defense Medical University Taiwan PF0057
13: Small Bowel Disease / Nutritional / Functional Disorder EP-398 Association of Recurrent Presentation and Abdominal Involvement with Adverse Outcomes in Paediatric IgA Vasculitis: A Large-Scale Retrospective Cohort Study Ruiheng Xie The Affiliated Hospital of Southwest Medical University China OF0276
13: Small Bowel Disease / Nutritional / Functional Disorder EP-399 Recurrent Enteric Infection, Helminth Exposure, and Barrier Dysfunction Converge in Pediatric Small Bowel Inflammation Across Tropical Slum Communities with Persistent Growth Faltering and Limited Diagnostic Access Rani Sulvianuri Bandung Institute of Technology Indonesia PF0419
13: Small Bowel Disease / Nutritional / Functional Disorder EP-400 Validation of Prediction Models for Obscure Gastrointestinal Bleeding Sung Chul Park Kangwon National University College of Medicine Korea PK0135
13: Small Bowel Disease / Nutritional / Functional Disorder EP-402 Early Clinical Impact of Double-Balloon Enteroscopy for Small-Bowel Disease in Mongolia Tsevelnorov Khurelbaatar Mongolian National University of Medical Sciences, Mongolia Japan Hospital of Mongolian National University of Medical Sciences Mongolia OF0341
13: Small Bowel Disease / Nutritional / Functional Disorder EP-403 Why Do Patients with Inflammatory Bowel Disease Avoid Certain Foods? A Systematic Review Nazihah Wafi University of Malaya Malaysia PF0428
13: Small Bowel Disease / Nutritional / Functional Disorder EP-404 Hemostasis of Refractory Small Bowel Angiodysplasia Bleeding Using Enteroscopy-Guided Argon Plasma Coagulation (APC): A Longitudinal Case Study) Uyanga Bilegt First Central Hospital of Mongolia Mongolia OF0241
14: Artificial Intelligence EP-405 Evaluation of a Retrieval-Augmented Generation-Based Large Language Model for Dietary Counseling in Patients with Inflammatory Bowel Disease Jae Gon Lee Hanyang University Guri Hospital Korea PK0321
14: Artificial Intelligence EP-406 Artificial Intelligence-Enhanced Video Capsule Endoscopy for Detecting Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Diagnostic Accuracy Mohamed Hamouda Elkasaby Faculty of Medicine, Al-Azhar University Egypt OF0076
14: Artificial Intelligence EP-407 Evaluating the Accuracy and Reproducibility of Large Language Models in Responding to Fertility-Related Queries in Inflammatory Bowel Disease: A Comparative Study of ChatGPT and DeepSeek Jun Deng The Sixth Affiliated Hospital of Sun Yat-sen University China OF0092
14: Artificial Intelligence EP-408 AI-Based Stochastic Epigenetic Modeling Distinguishes Low- and High-Grade Colorectal Adenomas Javad Alizargar National Taipei University of Nursing and Health Sciences Taiwan OF0074
14: Artificial Intelligence EP-409 Retrieval-Augmented Generation to Diagnose Inflammatory Bowel Disease: Integrating Treatment Guidelines with LightRAG Yan Zhang Qilu Hospital of Shandong University China OF0042
14: Artificial Intelligence EP-410 Comparative Evaluation of Multimodal Large Language Models for Computer-Assisted Endoscopic Assessment in Ulcerative Colitis Yue Shen The Affiliated Wuxi People' s Hospital , Nanjing Medical University China PF0022
14: Artificial Intelligence EP-412 Optimization of Machine Learning-Based Prediction for Adverse Events After Colonoscopy in the Elderly: A Multicenter Retrospective Study. Min-Jae Kim Yonsei University College of Medicine Korea PK0234
14: Artificial Intelligence EP-413 MRI-Based Radiomics Analysis for the Diagnosis of PFCD: An Artificial Intelligence Approach Yu Xiang The Affiliated Hospital of Nanjing University of Chinese Medicine China PF0200
14: Artificial Intelligence EP-414 An Ordinal Deep Learning Framework for Automated Endoscopic Grading of Crohn's Disease Yujie Zhou Zhongshan hospital of Xiamen University, Xiamen University China PF0046
14: Artificial Intelligence EP-415 Machine Learning Based Epidemiological Mapping of Inflammatory Bowel Disease Phenotypes in South Asia Dharmendra Khatri Nims University Jaipur India PF0034
14: Artificial Intelligence EP-416 Endoscopic Predictors of Clinical Severity in IgA Vasculitis Patients: A Single-Center Retrospective Cohort Study Quxin Juhou The Affiliated Hospital of Southwest Medical University China PF0003
14: Artificial Intelligence EP-417 A Study on Predicting Mucosal Healing of Infliximab Induction Therapy for Crohn's Disease Using Endoscopic Images and Reports Ruidong Chen The Second Affiliated Hospital of Soochow University, The First Affiliated Hospital with Nanjing Medical University China OF0208
14: Artificial Intelligence EP-418 Artificial Intelligence for Imaging Muscle Mass Related to Malnutrition and Sarcopenia - What Now and What Next (A Literature Review) Fathimah Khoerudini Yogyakarta State University Indonesia PF0241
15: Others EP-419 Potential and Limitations of Pre-Transplant Gut Microbiome Profiles for Predicting Acute GVHD After Allogeneic HSCT Yujin Hyun Kyungpook National University Korea PK0417
15: Others EP-420 Clinical Outcomes of Endoscopic Vacuum Therapy for Gastrointestinal Leakage, Perforation, and Fistula: A Single-Center Experience Seung Min Hong Pusan National University Hospital Korea PK0337
15: Others EP-421 Metabolomic Shifts in Blood and Feces Following Fecal Microbiota Transplantation Jung Newv Inha University Hospital, Inha University Hospital Korea PK0351
15: Others EP-422 Endoscopic Features and Clinical Course of Immune-Related Colitis After Durvalumab Plus Tremelimumab Therapy for Hepatocellular Carcinoma: A Single-Center Retrospective Study Kanako Higaki Department of gastroenterology and hepatology Japan PF0380
15: Others EP-423 Clinical Efficacy of Macrolide Antibiotics in Autoinflammatory Diseases with Gastrointestinal Involvement: A Retrospective Study Jiahui Zeng The First Affiliated Hospital of Sun Yat sen University China OF0379
15: Others EP-424 Occupational Risk Factors and Health Status Among Endoscopy Physicians and Staff: Results of a Questionnaire Survey Amarjargal Enkhbold Chinggis Avenue 41, Khan-Uul District, Ulaanbaatar 17040, Mongolia. Mongolia PF0309
15: Others EP-425 Factors Associated with Conservative Treatment Failure in Fulminant Colitis: A Retrospective Analysis of Clinical and Laboratory Predictors. Gleb Krotov The Loginov Moscow Clinical Scientific Center, Moscow Healthcare Department Russian Federation PF0030
15: Others EP-426 Associations Between BBPS and Polyp Detection Rate: A Retrospective in Single-Center Study Buyantogtokh Purevdorj Family medical hospital Mongolia PF0420
15: Others EP-427 Oral Sulfate Solution in Obese Patients as Preparation for Colonoscopy: A Prospective, Multicenter Trial Hyun Seok Lee School of Medicine, Kyungpook National University Korea PK0108
15: Others EP-428 Gastrointestinal Manifestations, Triggers, and Genetic Spectrum of Hereditary Angioedema: A Multicenter Retrospective Study from China Qing Xu 19805051057 China PF0206
15: Others EP-429 Revisiting Goodsall's Rule in Complex Anterior Fistula-in-Ano in Immunocompromised Patients: Changing the Treatment Armamentarium of Surgeons Aini Ibrahim Universiti Malaysia Sarawak, Sarawak General Hospital Malaysia OF0342
15: Others EP-430 Mesenchymal Stem Cells Promote Mucosal Healing by Remodeling Fibroblast Function via PDGF-AA-Mediated PI3K/AKT Signaling Zhaopeng Huang The Sixth Affiliated Hospital, Sun Yat-sen University, Biomedical Innovation Center, The Sixth Affiliated Hospital, Sun Yat-sen University, Center for Clinical Research, The Sixth Affiliated Hospital, Sun Yat-sen University China OF0275
15: Others EP-433 Studying the Significance of Brown Slits Sign in Colon Adenoma Using NBI and Magnification Function of OLYMPUS X1 Bilguun Jargalsaikhan Central Hospital of MNUMS Mongolia PF0082
15: Others EP-434 A Case of Pediatric Eosinophilic Esophagitis with IgE-mediated Allergic Response to Probiotics Hyo-Jeong Jang School of Medicine Keimyung University, Dongsan Medical Center Korea PK0359
15: Others EP-435 Eosinophilic Gastrointestinal Disease with Ascites Mimicking Crohn's Disease in a Patient with Prior Intestinal Tuberculosis: A Case Report Phat Luu Tam Anh General Hospital Vietnam PF0403
15: Others EP-436 Case Report: Rectal Neuroendocrine Tumor Treated with Endoscopic Submucosal Dissection at Nguyen Trai Hospital Thi Xuan Dung Do Nguyen Trai Hospital Vietnam PF0300
15: Others EP-437 Phytochemical Analysis of the Traditional Medicine Khamba TD-8 Used for Inflammatory Bone Diseases Sarana Enkhsaikhan Otoch Manramba University Mongolia OF0308
15: Others EP-438 Gastrointestinal Amyloidosis: Diagnostic and Therapeutic Challenges in Vietnam Ngan Le Thanh Quynh Tam Anh general hospital Vietnam OF0311
15: Others EP-439 "Severe Hypoalbuminemia and Polyserositis as Rare Complications of Pseudomembranous Colitis: A Case Report" Misheel Boldbaatar Second Central Hospital of Mongolia, Ulaanbaatar, Mongolia Mongolia PF0192
15: Others EP-440 Dasatinib-Associated Gastrointestinal Toxicity: A Case Series and Review Shyn Yi Tan Singapore General Hospital Singapore OF0101